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Abstract 
Carotenoids are lipophilic isoprenoid compounds synthesized by all photosynthetic organisms 
and some non-photosynthetic bacteria and fungi. With some notable exceptions, animals 
(including humans) do not produce carotenoids de novo but take them in their diets. In 
photosynthetic systems carotenoids are essential for photoprotection against excess light and 
contribute to light harvesting, but perhaps they are best known for their properties as natural 
pigments in the yellow to red range. Carotenoids can be associated to fatty acids, sugars, 
proteins, or other compounds that can change their physical and chemical properties and 
influence their biological roles. Furthermore, oxidative cleavage of carotenoids produces smaller 
molecules such as apocarotenoids, some of which are important pigments and volatile (aroma) 
compounds. Enzymatic breakage of carotenoids can also produce biologically active molecules in 
both plants (hormones, retrograde signals) and animals (retinoids). Both carotenoids and their 
enzymatic cleavage products are associated with other processes positively impacting human 
health. Carotenoids are widely used in the industry as food ingredients, feed additives, and 
supplements. This review, contributed by scientists of complementary disciplines related to 
carotenoid research, covers recent advances and provides a perspective on future directions on 
the subjects of carotenoid metabolism, biotechnology, and nutritional and health benefits. 
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Introduction 
Carotenoids are isoprenoid metabolites synthesized by all photosynthetic organisms 
(including plants, algae and cyanobacteria) and some non-photosynthetic archaea, bacteria, fungi 
and animals. In photosynthetic systems, carotenoids participate in light harvesting and they are 
essential for photoprotection. By contrast, carotenoids in non-photosynthetic tissues and 
organisms play a role as pigments in the yellow to red range. Carotenoids provide the autumn 
colors of many leaves (unmasked when chlorophylls are degraded) and they are responsible for 
the yellow color of corn, the orange color of carrots, pumpkin, and oranges, and the red color of 
tomato and watermelon, among others. In addition, carotenoids can be cleaved to produce 
compounds with roles as growth regulators, such as abscisic acid (ABA) and strigolactones, as 
well as bioactive molecules. Most animals (including humans) do not synthesize carotenoids de 
novo but take them in the diet and use them as essential precursors for the production of 
retinoids such as vitamin A. Additionally; carotenoids have been proposed to confer other health 
benefits whose discovery is spurring their use in functional food products. It is expected that the 
growing demand for natural carotenoids will boost carotenoid biotechnology as a fundamental 
player to meet the requirements of consumers and industry for this family of healthy pigments in 
the next few years. In this review, we summarize the current knowledge on carotenoids in three 
major areas: (1) metabolism and function, (2) crop biotechnology, and (3) nutrition and health.  
 
1. Chemical features 
1.1. Structure 
1.1.1. Classes and subclasses 
Carotenoids are isoprenoid compounds with a polyene backbone that contains a variable 
number of conjugated double bounds (c.d.b.), a feature that imparts carotenoids the property to 
absorb visible light resulting in their characteristic coloration in the yellow to red range. The 
Carotenoid DataBase (http://carotenoiddb.jp) provides at present information on chemical 
structures of 1,158 carotenoids found in 691 organisms from all domains of life [1]. Depending on 
the presence or absence of end rings in their structure, they are classified as cyclic or acyclic 
carotenoids. The numbering scheme in a cyclic and an acyclic carotenoid and the different basic 
end groups described in carotenoids are depicted in Figure 1 [2]. Another classification of 
carotenoids is based on their chemical composition. Those formed exclusively by carbon and 
hydrogen atoms are called carotenes, whereas carotenoids containing oxygen are known as 
xanthophylls. Oxygenated radicals common in dietary xanthophylls are hydroxyl (lutein, 
zeaxanthin), epoxide (violaxanthin, neoxanthin) or carbonyl (canthaxanthin, capsanthin) groups 
(Figure 2). However, other oxygenated groups can be found in natural carotenoids, including 
carboxylic, acetate, lactone, or sulphate groups [2, 3].  
Apart from these two general classifications, subclasses of carotenoids can be established 
considering their number of carbons and double bonds [3]. Typical carotenoids contain 40 carbon 
atoms (C40) and are formed by the condensation of eight C5 isoprenoid units (see Section 2 
below). While C40 carotenoids are the most abundant in nature, some carotenoids are shorter 
(C30) or longer (C45 or C50). C30 carotenoids only contain six C5 isoprenoid units, whereas C45 
and C50 carotenoids contain nine or ten isoprenoid units, respectively. One example is 
decaprenoxanthin, a C50 carotenoid (Figure 2). Furthermore, carotenoids can be cleaved to lose 
fragments at one or both ends of the molecule, hence generating apocarotenoids such as 
crocetin, a C20 compound (Figure 2). The term apocarotenoid is widely used in the literature to 
refer to all carotenoid cleavage products, but this is not strictly correct. Non-apocarotenoid 
carotenoid cleavage products include norcarotenoids, which lack one, two or three carbon atoms 
in the central hydrocarbons skeleton. An example is peridinin (Figure 2). Another subclass is that 
of secocarotenoids, in which a bond between adjacents carbons (except carbons 1 and 6 in rings) 
is broken. An example is semi-β-carotenone (Figure 2). While typical carotenoids contain a 
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double bond between the carbons 15 and 15’, the series of conjugated double bonds is shifted in 
retrocarotenoids such as rhodoxanthin (Figure 2).  
 
1.1.2. Geometrical and optical isomers 
Given the presence of double bonds in carotenoid molecules, multiple geometrical 
(cis/trans or Z/E) isomers could be formed, although in most cases there are important steric 
hindrances [4]. Isomers cis and trans differ considerably in shape (Figure 3). Normally, natural 
carotenoids are mostly in their all-trans configuration, which seems to be the most stable. 
However, this might not be the case of acyclic carotenoids such as lycopene, phytoene or 
phytofluene [5, 6]. Although the presence of cis isomers in foods and other matrices can be due 
to isomerization caused by heat or light [7, 8], it is well established that some can also occur 
naturally. A relevant example is (15-cis)-phytoene, which is the predominant phytoene isomer in 
carotenogenic organisms [9]. In addition, a small but biologically relevant proportion of some 
carotenoids must be in the cis configuration to be functional in the light-harvesting complex as 
well as in the formation of carotenoid-derived hormones. Thus, strigolactones are produced from 
(9-cis)-β-carotene and ABA is derived from 9-cis isomers of violaxanthin and neaxanthin (Figure 
4). Other examples are the accumulation of the highly sterically hindered (7,9,7’,9’)-tetra-cis 
isomer of lycopene (known as prolycopene) in the tomato tangerine mutant [10] and the natural 
occurrence of diverse cis isomers of phytofluene, antheraxanthin and violaxanthin in some fruits 
[5, 11-14]. Analyzing the presence of geometrical isomers of carotenoids in natural sources and 
foods is important as they exhibit different properties that may have an impact on functionality 
and bioavailability [15, 16] and can also be markers of certain technological treatments [17]. 
Many carotenoids contain chiral centers in their molecules, and hence optical isomers 
can occur. A typical example is zeaxanthin (Figure 3). Two optical isomers, namely (3R-3’R)-
zeaxanthin and (3R-3’S)-zeaxanthin (meso-zeaxanthin) are found in the macula lutea of the 
human retina [18]. Strikingly, there are not good known dietary sources of meso-zeaxanthin, 
although it is present in egg yolks of hens fed with this optical isomer [19]. Indeed, meso-
zeaxanthin is thought to be formed from lutein in the retina [20].  
 
1.1.3. Association with other molecules 
Carotenoids can be associated with other molecules, including fatty acids, sugars or even 
proteins. Xanthophylls are typically found esterified with fatty acids in many fruits [21-24] and 
other plant organs such as flowers [25] and tubers [26]. Similarly, there are carotenoids 
associated to sugar moieties, as it is the case of crocetin [27]. On the other hand, some 
carotenoids can form complexes with proteins (carotenoproteins) that are watersoluble and 
appear to stabilize carotenoids [28]. 
 
1.2. Physicochemical properties 
With very few exceptions, carotenoids are very lipophilic, and they are usually found in 
hydrophobic milieus [2]. Their esterification with fatty acids further increases their lipophilicity, 
whereas their association with proteins or sugars decreases it. But the main feature of 
carotenoids is their conjugated double bond system, which is the main responsible for their color 
(chromophore), shape, reactivity, and photochemical properties (essential in photosynthesis, see 
Section 2). Most carotenoids absorb blue and violet light (400-500 nm) and hence exhibit colors 
in the yellow to red range. The relationship between structural features and color changes has 
been studied in common food carotenoids [13]. The color of carotenoids depends on factors such 
as concentration, aggregation or interaction with proteins [2, 13]. Carotenoproteins can exhibit 
blue, purple, green, and brown colors [29]. For example, the carotenoprotein α-crustacyanin 
absorbs at 632 nm and exhibits a blue color, while the associated carotenoid (astaxanthin) 
absorbs maximally at 478 nm and is reddish when isolated [30]. The polyene chain can also 
determine the shape of the carotenoid molecule. For example, it is responsible for the rigid and 
rod-like shape of the (all-trans)-isomers of carotenoids [2]. The unique properties of phytoene 
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and phytofluene (Figure 2) mostly result from their fewer number of conjugated double bonds, 
which makes them colorless [31] and less rigid [32]. Both carotenes also exhibit different 
antioxidant capacity [33] as the conjugated double bond system is rich in electrons and it largely 
influences the antioxidant or pro-oxidant activities of carotenoids.  
 
2. Metabolism and function  
2.1. Carotenoids in plants 
2.1.1. Biological functions 
Carotenoids have both primary (i.e. essential) and secondary (i.e. specialized) functions in 
plants. Because carotenoids are indispensable for photoprotection against photooxidative 
damage, complete absence of carotenoids, e.g. by loss of function of PSY activity [34], results in 
an albino phenotype and a developmental block in the light. Carotenoids mitigate the harmful 
effects associated to strong light by dissipating the excess energy as heat (non-photochemical 
quenching, NPQ), by scavenging free radicals, and by protecting membranes from lipid 
peroxidation [35]. The regulation of NPQ is intrinsically linked to the xanthophyll cycle. The 
violaxanthin-antheraxanthin-zeaxanthin cycle (VAZ cycle) is the predominant xanthophyll cycle in 
most model plants, whereas many neotropical and woody plant species use the lutein epoxide 
(LxL) cycle [36-38] (Figure 4). Photoprotective functions are critical for the adaptation of plants to 
different light conditions and changing environments. Carotenoids are also part of the reaction 
center of photosystem II, playing a role in the assembly of pigment-protein complexes and the 
electron flow cycle to chlorophyll [39]. Another primary function of carotenoids is to serve as 
precursors of phytohormones such as ABA and strigolactones, which are key regulators of 
growth, development, and stress responses in plants [40]. Carotenoid-derived molecules also 
play roles as signals for plastid-to-nucleus and long-distance communication in plants. The 
identity of most of these signals remains to be identified (see Section 2.3 below). 
As secondary metabolites, carotenoids play important roles in the communication of plants 
and animals. Their colors contribute to attract pollinators (in the case of flowers) and seed 
dispersing animals (in fruits) [41, 42]. This role is also fulfilled by carotenoid cleavage products 
which function as water-soluble pigments (e.g. bixin) and volatile aromas (e.g. β-ionone).  
 
2.1.2. Biosynthetic pathway 
In plants, carotenoids are C40 isoprenoids synthesized in plastids. Their biosynthesis and 
metabolism have been covered in recent reviews [43-45]. Carotenoids are formed by the 
condensation of the universal C5 isoprenoid precursors isopentenyl diphosphate (IPP) and 
dimethylallyl diphosphate (DMAPP). These precursors are produced by two independent 
pathways in plants: the mevalonate (MVA) pathway and the methylerythritol 4-phosphate (MEP) 
pathway (Figure 4). In the MVA pathway IPP is formed in the cytosol from three molecules of 
acetyl-CoA and then isomerized to DMAPP, whereas both IPP and DMAPP are formed in the 
plastid from pyruvate and glyceraldehyde 3-phosphate by the MEP pathway [46]. Plant 
carotenoids are produced from MEP-derived precursors in plastids (Figure 4). Different lines of 
evidence support a limiting role of the MEP pathway for carotenoid biosynthesis [43]. Metabolic 
flux analyses have shown that the first enzyme of the MEP pathway, deoxyxylulose 5-phosphate 
synthase (DXS), is also the one with the highest flux control coefficient [47]. DXS activity is highly 
regulated at multiple levels [48]. Besides the primary control derived from the regulation of gene 
expression, a fine control is exerted within plastids through the regulation of enzyme levels. 
Within plastids, DXS is prone to misfolding and aggregation. Under normal growth conditions, 
non-functional forms of the enzyme are recognized by a specific J-protein and delivered to 
degradation by the stromal Clp protease complex [49-51]. Under stress conditions, however, a 
refolding pathway is induced to reactivate the enzyme [50, 52]. DXS activity can also be repressed 
by a feedback mechanism involving IPP and DMAPP [34, 53]. Other enzymes of the MEP pathway 
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are regulated by the Clp protease [49, 54] but also by redox signals through direct interaction 
with thioredoxin [48].  
Condensation of three IPP and one DMAPP molecules generates geranylgeranyl 
diphosphate (GGPP), the direct metabolic precursor not only for carotenoids but also for several 
other plastidial isoprenoids with important functions in photosynthesis (chlorophylls, 
tocopherols, plastoquinones, and phylloquinones), growth regulation (gibberellins), or 
environmental interactions (diterpenes), among others (Figure 4). Thus, different metabolic 
pathways compete for the GGPP available in the plastids [55, 56]. Plastidial GGPP synthase 
(GGPPS) isoforms physically interact with enzymes that use GGPP for the production of 
downstream products, including carotenoids [55, 57]. However, overexpression of GGPP-
producing enzymes from different sources has shown only slight effects on plant carotenoids 
levels [57-60].  
The first committed step of plant carotenoid biosynthesis is the condensation of two C20 
GGPP molecules to form C40 15-cis-phytoene (Figure 4). This step, catalyzed by the enzyme 
phytoene synthase (PSY), is generally accepted to be the main rate-determining reaction of the 
pathway and to control the metabolic flux to carotenoids [43, 61]. PSY is typically encoded by 
small gene families that are differentially expressed in response to developmental and 
environmental signals [44]. Transcription factors involved in the regulation of PSY-encoding genes 
have been identified in different plant species [41, 62]. PSY is also regulated at the enzyme level 
in response to a variety of factors, including plastidial sublocalization [63, 64] (see Section 2.1.3 
below). Similar to DXS and other MEP pathway enzymes, the levels and activity of PSY and other 
carotenoid pathway enzymes can also be regulated by the Clp protease [65, 66], a mechanism 
that likely contributes to coordinate carotenoid biosynthesis with the supply of their metabolic 
precursors. Other mechanisms regulating PSY activity in different plant systems are (1) direct 
interaction with the ORANGE (Or) chaperone [67, 68], (2) direct interaction with the STAY-GREEN 
protein [69], and (3) negative feedback by downstream carotenoids [70, 71].  
In plant cells, 15-cis-phytoene is converted to all-trans-lycopene by sequential desaturation 
and isomerization reactions (Figure 4). Desaturations are catalyzed by phytoene desaturase (PDS) 
and ζ-carotene desaturase (ZDS). In concert with these steps, ζ-carotene isomerase (ZISO) 
catalyzes the cis to trans conversion of the product of PDS, whereas carotenoid isomerase 
(CRTISO) transforms tetra-cis lycopene (prolycopene) into all-trans-lycopene (Figure 4). The 
somewhat unexpected discovery of ZISO is a good example of how incomplete is our knowledge 
of the carotenoid pathway even after decades of study [72]. ZISO remained unknown in part 
because its isomerization activity can be compensated by the photoisomerization of carotenoids 
in green tissues, similar to that reported for CRTISO [44]. Both PDS and ZDS, which are important 
to control flux though the carotenoid pathway [73, 74], require the operation of an electron 
transfer process involving the plastidial terminal oxidase (PTOX) and plastoquinone. The 
plastoquinone pool available for carotenoid biosynthesis has been associated to electron 
transport processes linked to chlororespiration and chromorespiration [75, 76]. In turn, 
chromorespiration has also been related with the supply of ATP required for carotenoid 
biosynthesis in non-photosynthetic plastids [75, 77]. The recent report that ZISO requires a 
redox-regulated heme cofactor for activity [78] highlights the relevance of the redox status of the 
plastids in the regulation of the carotenoid pathway.  
The cyclization of lycopene is a critical step for the synthesis of carotenoids since it is the 
first branching step of the pathway (Figure 4). The action of lycopene ε-cyclase (LCYE) or 
lycopene β-cyclase (LCYB or CYCB, the latter term often used for chromoplast-associated 
isoforms such as the one expressed in tomato ripening fruit) generates carotenoids with ε- or β-
ionone rings, respectively. The cyclization of both ends of the linear lycopene molecule by LCYB 
generates β-carotene, while the coordinated action of LCYE and LCYB produces α-carotene 
(Figure 4). Cyclization of both ends of lycopene with ε rings is very uncommon in nature. Genes 
encoding LCYB and LCYE share significant sequence identity, suggesting that they may have 
originated by duplication of a common ancestor. Moreover, specific signatures have been 
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identified in their sequences that appear to be responsible for the cyclization at one or other end 
of lycopene [45]. The coordinated operation of LCYE and LCYB cyclases plays a major role in the 
regulation of the metabolic flux of the carotenoid pathway to either the β,β or the β,ε branch 
[44, 79].  
Xanthophylls are oxygenated carotenoids derived from α- or β-carotene (Figure 4). They 
are among the main carotenoids in photosynthetic tissues. Xanthophyll formation requires ring-
specific hydroxylation reactions. In the case of β-carotene, two sequential hydroxylation of the β 
rings produce first β-cryptoxanthin and then zeaxanthin (Figure 4). This reaction is normally 
catalyzed by carotene β-hydroxylase enzymes of the non-heme di-iron (BCH) type [43, 44, 70, 
80]. While BCH enzymes can also participate in the biosynthesis of lutein from α-carotene, the 
hydroxylation the β ring of α-carotene to produce zeinoxanthin is usually catalyzed by CYP97A, a 
heme-containing cytochrome P450 enzyme [43, 44, 70, 80]. A similar enzyme, CYP97C, acts as a 
carotene ε-hydroxylase to transform zeinoxanthin into lutein (Figure 4). Alternatively, CYP97C 
can first hydroxylate the ε ring of α-carotene to produce α-cryptoxanthin and then CYP97A can 
hydroxylate the β ring of α-cryptoxanthin to produce lutein (Figure 4).  
Zeaxanthin epoxidase (ZEP) introduces epoxy groups in the rings of zeaxanthin, resulting in 
the sequential formation of antheraxanthin and violaxanthin (Figure 4). These reactions can be 
reverted by violaxanthin de-epoxidase (VDE). Interconversion of zeaxanthin and violaxanthin is 
known as the VAZ cycle (Figure 4). In plants with the LxL cycle, lutein can be converted into lutein 
epoxide (and vice versa) by particular ZEP and VDE enzymes [38]. The introduction of an allenic 
double bound in the violaxanthin molecule produces neoxanthin in a step catalyzed by 
neoxanthin synthase (NSY). The identity of the enzyme and the mechanism of action, however, 
remain unclear.  
In most fruits and flowers, as well as in many seeds and some tubers, xanthophylls are 
mono- or diesterified with different fatty acids [24, 81, 82]. This modification increases their 
lipophilicity and stability. The increased lipophilicity conferred by the acyl chains may favor their 
sequestration in the hydrophobic core of plastoglobules, thylakoid-associated lipoprotein 
structures enclosed by a lipid monolayer which are a major site for the massive storage of 
esterified carotenoids [83]. An esterase-related protein, referred to as PYP (Pale Yellow Petal), 
has been identified as the enzyme responsible for xanthophyll esterification in tomato flowers 
[84]. The co-localization of xanthophyll biosynthetic enzymes and PYP in plastoglobules may 
allow an efficient esterification process. At present very little is known about the regulatory role 
of xanthophyll acyltransferases in carotenoid accumulation. Some experiments have shown that 
xanthophyll acyltransferases are very selective for the acyl moiety and present a marked 
regioselectivity when asymmetric xanthophylls, such as lutein, are esterified [81]. The acyl donor 
molecules involved in the xanthophyll esterification process remain unidentified. 
 
2.1.3. Enzyme distribution within plastids 
The subplastidial localization and organization of carotenogenic enzymes is an essential 
question that remains little explored despite its relevance to fully understand carotenoid 
biosynthesis in plants. A previously published model [85] proposing the formation of 
multienzymatic complexes for carotenoid biosynthesis channeling has been recently supported 
by new evidence [43, 63, 78, 79, 86-88]. Carotenoid biosynthetic enzymes appear to be either 
associated to envelope and thylakoid membranes (PSY, PDS, ZDS, CRTISO, LCYB, LCYE, CYP97A 
and CYP97C) or integral membrane proteins (ZISO, BCH) [43, 63]. VDE attaches to the thylakoid 
membrane at acidic pH but behaves as a soluble lumenal protein at neutral pH [89]. PSY has also 
been found in plastoglobules or the stroma of chloroplasts from different species [64, 90], while 
in the plastids of dark-germinated seedlings (i.e. etioplasts) the enzyme was mainly associated to 
prolamellar bodies, membrane aggregations of semicrystalline structures often arranged in a 
geometric configuration [91]. Interestingly, PSY localization in prolamellar bodies was linked to 
low enzymatic activity while association to thylakoid membranes during the de-etiolation process 
resulted in a substantial increase in activity [91].  
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When chloroplasts differentiate into chromoplasts (plastids specialized in carotenoid 
biosynthesis and storage), synthesis of carotenoids is tightly associated to plastoglobules or other 
membranous structures derived from thylakoidal disassembly. It is common that particular 
isoforms of carotenoid biosynthetic enzymes are preferentially expressed in chromoplast-
containing tissues. In tomato, for example, isoforms PSY1, CYCB and BCH2 (CRTR-B2) participate 
in carotenoid biosynthesis in chromoplasts whereas PSY2, LCYB and BCH1 (CRTR-B1) are found in 
chloroplasts [92]. In tomato chromoplasts PSY is active when soluble [93] and it associates with a 
multienzymatic complex with IPP/DMAPP isomerase (IDI) and GGPPS enzymes [94]. In 
chromoplasts of daffodil and cauliflower, PSY and PDS have been found in membrane-bound 
form and soluble in the stroma but only the membrane-associated enzymes are predicted to be 
active [86, 91]. Other downstream enzymes of the pathway such as ZDS, LCYs, BCH, and PYP have 
been identified in the plastoglobule proteome from chromoplasts of different species, supporting 
the crucial role of these subcompartments in the channeling and production of carotenoids [43, 
63, 83, 87, 88, 90].  
 
2.1.4. Storage in plastids 
The final accumulation of carotenoids in plastids not only depends on (1) the biosynthetic 
rate (e.g. the supply of MEP-derived precursors and the levels and activity of biosynthetic 
enzymes) but also relies on (2) the availability of plastidial structures for their sequestration and 
storage, and on (3) the carotenoid degradation rate. The presence of suborganellar membranous 
systems and other carotenoid-sequestering structures depends on the plastid type, whereas the 
predominant plastid type in a tissue determines the capacity of the tissue to produce and store 
carotenoids [41, 95, 96]. Meristematic tissues contain proplastids, which are undifferentiated 
plastids without the capability to synthesize carotenoids. Amyloplasts and elaioplats are 
specialized plastids from non-photosynthetic tissues (e.g. seeds, tubers or fruits) which store 
large quantities of starch and lipids, respectively, and contain variable amounts of carotenoids 
[97]. Etioplasts are characterized by the presence of prolamellar bodies [98]. Besides chlorophyll 
precursors, they contain low amounts of carotenoids, mainly violaxanthin and lutein, that 
contribute to greening when etioplasts differentiate into chloroplasts after exposure to light [99, 
100]. Chloroplasts are the best studied plastids since they are the site of photosynthesis in green 
plant tissues. In chloroplasts, carotenoids are localized in the envelope, grana and thylakoid 
membranes, and reaction centers of photosystems [39]. The carotenoid composition of 
chloroplasts is quite similar in all plants. The predominant carotenoids in green tissues of plants 
grown under normal light conditions are lutein, β-carotene, violaxanthin, and neoxanthin, with 
lower amounts of zeaxanthin and α-carotene. This profile can change in response to 
developmental (e.g. senescence) or environmental challenges. Notably, under bright light, the 
VAZ cycle leads to a strong increase in zeaxanthin and the LxL cycle to higher levels of lutein to 
improve photoprotection (Figure 4).  
In chloroplasts, only a reduced proportion of carotenoids are localized in plastoglobules. In 
other plastid types, however, plastoglobules can be the main structure for carotenoid deposition 
[83]. This is the case of some types of chromoplasts [95, 101, 102]. Chromoplasts are plastids 
specialized in carotenoid biosynthesis and storage. derive from other plastid types, including 
chloroplasts [101, 102]. According to the major internal substructures, chromoplasts can be 
classified as globular, tubular, crystalloid or membranous [95, 103]. This diversity reflects the 
wide variety of carotenoid profiles found in chromoplasts from different plant species, tissues, 
organs, or developmental stages. Interestingly, different chromoplast types and substructures 
can coexist in the same tissue [101, 104]. A strong relationship between carotenoid deposition 
form and their bioavailability has been established, making this an attractive area of 
development for food research specialists [103] (see Section 4.3 below). Globular chromoplasts 
contain carotenoids in plastoglobules where more apolar carotenes or esterified xanthophylls are 
lipid-dissolved in the core of the globule and polar carotenoids are associated with the 
surrounding lipid monolayer [105]. Carotenoids stored in plastoglobules are very stable. In 
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tubular chromoplasts, carotenoids are in a liquid crystalline state and sequestered in the core of 
a tube surrounded by a monolayer of glycolipids and phospholipids. Tubular structures are 
usually associated with plastoglobules in globular-tubular chromoplasts [103]. Crystalloid 
chromoplasts, typically found in tissues that accumulate large amounts of β-carotene or 
lycopene, contain solid carotenoid crystal structures surrounded by a lipid bilayer [106]. 
Membranous chromoplasts, identified only in few species and tissues, are characterized by the 
presence of concentric internal stacked membranes [106, 107]. Recently, it has been shown that 
transgene-mediated overproduction of the DnaJ-like protein ORANGE (Or) induces the biogenesis 
of β-carotene-enriched membranous chromoplasts with higher carotenoid sink strength [100]. 
The Or protein was first identified as responsible for the orange color of the curd of the 
cauliflower Or mutant [108, 109]. A specific role of Or in triggering chromoplast differentiation 
has been confirmed in different plant systems using transgenic approaches [100, 109-111]. 
However, the increase in carotenoid levels induced by Or overexpression in rice and maize seed 
endosperm does not correlate with the differentiation of proplastids into chromoplasts [112, 
113]. Furthermore, Or may also promote carotenoid accumulation by increasing PSY activity [67, 
68] and by inhibiting the conversion of β-carotene into downstream products [114]. Although a 
few other proteins (e.g. fibrillins) have been associated with increased levels of carotenoids in 
chromoplasts [115, 116], the Or protein is the only one known to have a major role in triggering 
the differentiation of chromoplasts.  
 
2.2. Carotenoids in non-plant systems 
2.2.1. Archaea and non-photosynthetic bacteria 
In contrast to eukaryotes, that only produce C40 or C40-derived carotenoids, bacteria 
synthesize all C45 and most of the C30 and C50 carotenoids found to date, while the rest are 
produced by archaea. The Carotenoid DataBase [1] includes 307 carotenoids from 170 bacterial 
species and 19 carotenoids from 9 species of archaea. Another valuable tool dedicated to 
organize and classify the diverse carotenoids found in bacteria and archaea is the Prokaryotic 
Carotenoid DataBase, ProCarDB (http://bioinfo.imtech.res.in/servers/procardb/). ProCarDB [117] 
presently displays 289 carotenoids distributed in acyclic (40), cyclic (31), hydroxycarotenoids (also 
known as carotenols) (75), and hydroxycarotenoids with cyclic structures (143). In addition, 
ProCarDB assigns the different carotenoids to 48 pathways.  
Although carotenoid biosynthesis is less common in archaea, it has been described in 
Halobacterium salinarum, Halorubrum chaoviator, Halococcus morrhuae, Natromonas pharaonis 
and Haloarcula japonica. Recently, other carotenoid-producing haloarchaea such as Haloferax 
volcanii and Haloferax mediterranei were characterized in salty ponds or marshes [118, 119]. The 
main final product of the carotenoid pathway in archea is the acyclic polyhydroxylated C50 
carotenoid bacterioruberin [120, 121] (Figure 5). For instance, in H. salinarum 5-cis, 9-cis, 13-cis, 
and all-trans-bacterioruberin isomers account for 13%, 4%, 11%, and 68%, respectively, of all 
carotenoids, whereas all-trans isomers of trisanhydrobacterioruberin and bisanhydro-
bacterioruberin correspond to 4% and 1%, respectively [121]. Bacterioruberin is not exclusive of 
archaea, as it has also been found in bacteria such as Azospirillum brasilensis, Micrococcus roseus, 
Rubrobacter radiotolerans, Arthrobacter agilis, Kocuria rosea or Thermus filiformis [121, 122]. 
While archaea use the MVA pathway to supply the isoprenoid precursors necessary to 
synthesize their carotenoids, most bacteria use the MEP pathway. A minority of bacteria use the 
MVA pathway, and only a few of them use both pathways [123]. Phylogenetic analysis, however, 
suggests that the MEP pathway is the ancestral route in bacteria. In the case of non-
photosynthetic bacteria, most use IPP and DMAPP to produce C20 GGPP and downstream C40 
carotenoids. Representative examples are Erwinia sp., Myxococcus sp., Streptomyces sp., 
Alcaligenes sp., Flavobacterium sp., Agrobacterium aurantiacum (Paracoccus sp.) and Thermus 
thermophilus. Erwinia species accumulate β-cryptoxanthin, zeaxanthin, and glucosides of these 
xanthophylls [124]. Myxococcus fulvus produces 4-ketotorulene and some unique C40 
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carotenoids, such as myxobactin and myxobactone esters (Figure 5) [125, 126]. By contrast, 
Clostridia and Bacilli, such as Staphylococcus aureus, Streptococcus faecium, Heliobacillus 
fasciatum, and Heliobacterium, produce C30 carotenoids through the diapocarotene or C30 
bacterial pathway (Figure 5), which uses C15 farnesyl diphosphate (FPP) as the prenyl 
diphosphate precursor instead of GGPP [127]. This pathway produces different acyclic 
compounds derived from 4,4’-diapolycopene or 4,4’-diaponeurosporene, such as OH-
diaponeurosporene glucoside ester or 4,4’-diapolycopene-4,4’-dioic acid diester (Figure 5). 
The identification of the first prokaryotic genes for carotenoid biosynthesis settled a 
terminology (crt) that has been maintained to refer to homologous genes in many other bacteria 
(Table 1). The genes encoding GGPP synthase (CrtE), phytoene synthase (CrtB), phytoene and -
carotene desaturases (CrtI and CrtQ), and lycopene cyclase (CrtY) are conserved between non-
photosynthetic and anoxygenic photosynthetic bacteria, and similar genes are also found in algae 
and plants. Hydroxylations and glycosylations are carried out by CrtZ and CrtX, respectively. 
Enzymatic activities of the Erwinia enzymes were demonstrated by heterologous expression of 
one or several crt genes in engineered strains of Escherichia coli, a non-carotenogenic host [128]. 
This experimental system has actually allowed biochemical assignments for many carotenoid 
biosynthetic genes from both prokaryotic and eukaryotic organisms. Genes for bacterial 
carotenoid biosynthesis and regulation are usually organized as operons. Streptomyces coelicolor 
has two crt operons, crtEIBV and crtYTU [129]. In Flavobacterium sp, the genomic orientation of 
the crt cluster is different to other bacteria, as crtE gene is transcribed oppositely to the crtZYIB 
operon [130]. In some species, the crt genes are extrachromosomal. This is the case of Thermus 
thermophiles, where the crt operons are located in a 260-kb circular plasmid named pTT27 [129]. 
Carotenoid biosynthesis is regulated by different environmental stimuli, being light the 
most studied. Light promotes the synthesis of carotenoids in Myxococcus xanthus, S. coelicolor 
and T. thermophilus, among others [129]. This photoregulatory mechanism has been studied in 
detail in M. xanthus, where light is detected by the blue-light receptor CarF through the 
formation of singlet oxygen (1O2) in the membrane [131]. Blue light excites protoporphyirin IX 
(PPIX) to 3PPIX and this converts O2 in 
1O2. The singlet oxygen is detected by CarF, which in turn 
interacts with CarR to inactivate it [132]. CarR is an anti-σ factor that sequesters σ factor CarQ in 
the dark. In the presence of blue light, CarQ is free to bind to the core of RNA polymerase and to 
activate PQRS and PI promoters of the regulatory carQRS operon and the crtIb gene. Both 
promoters also need the regulatory complex CarD/CarG for their transcription. The rest of the 
genes involved in carotenoid biosynthesis are in two linked operons: carB (encoding 
carotenogenic genes crtE-Ia-B-D-C) and carA (crtYc-Yd-carA-carH). CarA and CarH are DNA-
binding repressors that are counteracted by CarS, that is induced by light from the carQRS 
operon [131]. 
In S. coelicolor, T. thermophilus and Bacillus megaterium, the MerR family transcriptional 
regulator LitR is very well conserved and uses adenosyl B12 as a light sensing ligand. In the dark, 
it behaves as a repressor of a sigma factor (LitS) but in the light LitR activates the transcription of 
litS and the carotenoid biosynthesis genes [129]. This regulation by light offers some clues on 
possible functions of carotenoids in non-photosynthetic prokaryotes. Carotenoids most likely act 
as antioxidants in non-photosynthetic bacteria, protecting against photooxidative protoporphyrin 
and heme molecules [133]. Carotenoid extracts of Deinococcus radiodurans, a radio-resistant 
species, protect against DNA-damaging agents [134, 135]. In the human pathogen S. aureus, 
staphyloxanthin contributes to the resistance to reactive oxygen species (ROS) and to the attack 
of neutrophils, being the role of this carotenoid to resist the host phagocytic defenses [136, 137].  
 
2.2.2. Photosynthetic bacteria 
Anoxygenic photosynthetic bacteria producing carotenoids include purple bacteria, green 
sulfur bacteria, and heliobacteria. Genes involved in carotenoid biosynthesis in these bacteria are 
listed in Table 1. The structures of the produced carotenoids differ from those of other 
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organisms, including non-photosynthetic bacteria. Most C40 carotenoids from these bacteria are 
acyclic and contain sulfate, methoxy, carbonyl, carboxyl, glycoside, and hydroxyl groups [127]. 
Five main carotenogenesis pathways have been proposed for anaerobic photosynthetic bacteria 
(Figure 5): (1) the spirilloxanthin pathway, that is divided in normal spirilloxanthin, unusual 
spirilloxanthin, spheroidene, and carotenal pathways. As an example, the purple bacteria 
Rhodospirillum rubrum, Rhodobacter capsulatus and Rhodobacter sphaeroides produce 
spirilloxanthin and spheroidene [138]; (2) the isorenieratene pathway, that also includes that 
producing chlorobactene. Purple and green sulfur bacteria such as Chlorobium tepidum and 
Chlorobium phaeobacteroides produce C40 carotenoids with aromatic rings such as 
isorenieratene and chlorobactene, the latter also present in actinobacteria; (3) the okenone 
pathway, that includes the okenone and the R.g-keto carotenoid pathways; (4) the γ- and β-
carotene pathway; and (5) the diapocarotene pathway, which in heliobacteria such as 
Heliobacillus mobilis, Heliophilum fasciatum, and Heliobacterium chlorum produces 
diapolycopene . There are additional pathways leading to carotenoid glucosides and acylated 
carotenoid glucosides (Figure 5). In the case of aerobic photosynthetic bacteria, most of them use 
the spirilloxanthin pathway [139]. 
Similar to plants, the main function of carotenoids in both anoxygenic and oxygenic 
photosynthetic bacteria is to protect from oxidative damage provoked by excess light in the 
presence of excited bacteriochlorophyll and oxygen. Carotenoids also have a light-harvesting 
function, as they absorb light and transfer it to the photosynthetic reaction center via 
bacteriochlophyll [133, 140]. In cyanobacteria, the oldest aerobic photosynthetic organisms and 
the origin of plant chloroplasts, carotenoids are also associated to photosynthesis and 
photoprotection, including the formation of diverse carotenoid-protein complexes [141, 142]. A 
well-known example is the Orange Carotenoid Protein, which contains a ketocarotenoid as 
photoresponsive chromophore. Absorption of blue-green light by the chromophore causes a 
structural change of the protein that triggers a photoprotective mechanism, decreasing the 
excess absorbed energy arriving at the photosynthetic reaction centers by increasing thermal 
dissipation at phycobilisomes [143]. 
Early studies identified -carotene as one of the major carotenoids in cyanobacteria [144], 
accompanied by oxidized derivatives such as zeaxanthin, canthaxanthin, -cryptoxanthin, and 
echinenone [145]. Genes homologous to those responsible for carotenoid biosynthesis in non-
photosynthetic bacteria are usually found in cyanobacteria, including those for the early steps 
(crtE, crtB, crtI, crtQ and crtL) and for downstream branches involving -carotene hydroxylase 
(crtR) and ketolase (crtO/crtW) genes (Table 1). Some cyanobacteria contain plant-type 
desaturase genes, as crtP instead of crtI for phytoene desaturation. Strikingly, cyanobacteria lack 
carotenoids that are abundant in eukaryotic photosynthetic species, such as lutein, violaxanthin 
or neoxanthin, and synthesize carotenoids not found in other taxa. These unique carotenoids 
include the zeaxanthin derivatives caloxanthin and nostoxanthin (with two hydroxyl groups in the 
 ring resulting from the activity of the crtG gene in Synecococcus sp.) and glycoside derivatives 
such as the myxol glycosides and oscillol diglycosides [146]. Only a gene involved in glycosylation, 
wcaG, has been identified so far [146]. Carotenoid genes are induced by light and their regulation 
is mediated by the transcription factor NtcA, which binds to the crt promoters in the presence of 
reductants and oxoglutarate [147].  
 
2.2.3. Microalgae 
Microalgae are a heterogeneous group of photosynthetic unicellular organisms living in 
water ecosystems. In contrast to fungi, microalgae exhibit a complex carotenoid metabolism 
[148, 149]. Similar to higher plants, they accumulate carotenoids involved in photosynthetic 
functions, e.g. photoprotectants and accessory light-absorbing pigments able to transfer energy 
to chlorophylls. Thus, microalgae frequently contain -carotene, violaxanthin, antheraxanthin, 
zeaxanthin, neoxanthin, and lutein [150]. Some carotenoids, however, are specific of certain 
12 
 
microalgae groups. The neoxanthin-related xanthophylls diatoxanthin, dinoxanthin, 
diadinoxanthin, and fucoxanthin are only found in diatoms such as those of the genus 
Phaeodactylum, while α-carotene, ε-carotene, δ-carotene or astaxanthin are only found in green 
algae (Figure 7) [148, 151]. Furthermore, stressing conditions such as nitrogen deprivation, strong 
solar irradiation, drought or hypersalinity cause some microalgae to accumulate large amounts of 
carotenoids that provide an intense reddish pigmentation to the stressed cells [152]. In this case, 
however, the carotenoids are not accumulated in the thylakoid membranes but in oily droplets or 
lipid vesicles located either in chloroplasts (in thylakoids) or in the cytoplasm (as oleosomes). To 
facilitate this, the biosynthesis of carotenoids in response to stress is metabolically coupled to a 
massive production of lipids [152, 153]. Well-known examples are the accumulation of -
carotene by Dunaliella salina, astaxanthin by Haematococcus pluvialis, and lutein by Muriellopsis 
sp. and Scenedesmus almeriensis [154, 155]. The large production of -carotene in D. salina under 
high solar irradiation, which reaches up to 10% dry weight [156], occurs in vegetative cells [157]. 
In H. pluvialis, however, green vegetative cells growing under favorable conditions produce 
mainly lutein and -carotene whereas exposure to stressing conditions results in the cessation of 
cell division and their transformation into cyst cells (called aplanospores) that accumulate 
astaxanthin up to 4 % of the total dry mass [158]. To facilitate storage, astaxanthin is mostly 
accumulated in the form of fatty acid esters. 
 
2.2.4. Fungi 
Carotenoid biosynthesis is a frequent trait in fungi, where the carotenoid pathways are 
simpler in comparison with photosynthetic organisms [159, 160]. In contrast to other 
carotenogenic organisms, fungal phytoene synthase and lycopene/carotene cyclase activities are 
encoded by a single gene, resulting in a bifunctional enzyme with amino and carboxyl domains 
similar to CrtY and CrtB, respectively. Fungi also harbor a single desaturase that achieves all the 
desaturation steps downstream of phytoene (either four or five, depending of the species). The 
production of -carotene is predominant in the mucormycotina group, with Phycomyces 
blakesleeanus, Mucor circinelloides and Blakeslea trispora as the best-known examples. Only two 
genes (one encoding the phytoene synthase/cyclase and the other the desaturase), usually 
divergently transcribed from a shared regulatory region, are needed for -carotene synthesis in 
these fungi. Accumulation of -carotene has also been described in fungi from other taxonomic 
groups, such as basidiomycotina (e.g. Ustilago maydis) [161], and ascomycotina (e.g., Cercospora 
nicotianae) [162].  
Other fungi produce xanthophylls (Figure 6). The most thoroughly investigated systems are 
those for the synthesis of neurosporaxanthin by the ascomycotina Neurospora crassa and 
Fusarium fujikuroi, and the production of astaxanthin and torularhodin by the basidiomycotina 
yeasts Xanthophyllomyces dendrorhous and Rhodotorula sp, respectively [160]. In the first case, 
five desaturations, a single cyclization and an oxidative cleavage reaction are needed to generate 
neurosporaxanthin. Astaxanthin biosynthesis requires the introduction of keto and hydroxyl 
groups in the terminal rings of -carotene (Figure 6). All the genes participating in 
neurosporaxanthin production in N. crassa and Fusarium sp, and astaxanthin production in X. 
dendrorhous have been identified [160]. The genes up to torulene biosynthesis were similar to 
those from other biosynthetic pathways, but the last two steps of neurosporaxanthin production 
were found to be carried out by two unique enzymes, a torulene-cleaving dioxygenase (a novel 
member of the carotenoid cleavage dioxygenase or CCD family, see Section 2.3 below) that 
produces β-apo-4’-carotenal [163, 164] and an aldehyde dehydrogenase that generates the 
terminal carboxy group [165, 166]. Less information is available on the genetics and biochemistry 
of torularhodin biosynthesis, which is similar to that of neurosporaxanthin but lacks a cleavage 
step (Figure 6). In the case of Fusarium, a side branch of neurosporaxanthin biosynthesis leads to 
-carotene, which can be then cleaved by another CCD enzyme to produce retinal, presumably 
used as chromophore by the Fusarium opsins [167]. The amenability of fungi to genetic 
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manipulation and industrial cultivation makes some of them ideal choices for biotechnological 
carotenoid production, as that of -carotene or lycopene by B. trispora, or astaxanthin by X. 
dendrorhous [168]. The availability of genetic engineering tools for X. dendrorhous has allowed its 
use for the production of alternative xanthophylls such as zeaxanthin [169] or new keto-
carotenoids [170]. 
In contrast to photosynthetic species, carotenoids appear to play only secondary roles in 
fungi. Loss of carotenoids in albino mutants of carotenogenic fungi does not have an impact on 
growth under laboratory conditions, whereas well-known fungal models such as the yeast 
Saccharomyces cerevisiae or the mold Aspergillus nidulans completely lack carotenoids. However, 
different lines of evidence suggest that carotenoids might exert protective roles against oxidative 
stress [171]. They also serve as precursors for bioactive molecules such as retinal, as indicated 
above. However, the incapacity to produce retinal has no significant consequences in F. fujikuroi, 
and mutants unable to produce CarO or OpsA rhodopsins have no apparent phenotypic 
alterations [172, 173]. In some mucormycotina, -carotene is also used as precursor in the 
synthesis of sexual hormones, known as trisporic acids, as well as other compounds [171]. The 
incapacity to produce trisporic acids in -carotene defective mutants of P. blakesleeanus results 
in an impairment to carry out the sexual cycle [174].  
 
2.2.5. Animals 
Animals were long believed to be incapable of synthesizing carotenoids de novo despite 
requiring them for communicative coloration and to serve as precursors for the production of 
retinoids (including vitamin A, biologically active molecules such as retinoic acid, and vision 
pigments). Carotenoids are actually taken from the diet or through symbiosis in most animals 
[175]. However, the previously assumed dogma that animals do not synthesize carotenoids has 
been challenged by the recent discovery of genes encoding carotenoid biosynthetic enzymes of 
fungal origin (bifunctional phytoene synthase/carotene cyclases and desaturases) in the genomes 
of arthropods such as hemipteran (aphids, adelgids, phylloxerids) and dipteran (gall midges) 
insects and mites [176-181]. The presence of these enzymes allows the endogenous production 
of carotenoids such as α-carotene, γ-carotene, β-carotene, torulene, dehydro-γ,ψ-carotene (a 
carotenoid similar to torulene) and ketocarotenoids in the animal hosts. The corresponding 
biosynthetic genes were likely incorporated to these phylogenetically distant arthropod genomes 
in different horizontal gene transfer events. Their presence appears to be of ecological 
significance because it determines color polymorphism and hence influences susceptibility to 
natural enemies [176]. Next-generation sequencing technologies should facilitate the discovery of 
more examples of transference of carotenoid-related genes from microbial to animal genomes. 
Animals that do not produce carotenoids de novo can instead accumulate them in 
particular tissues. Mammals have been traditionally divided into “white-fat” (pig, sheep, goat, 
carnivores and rodents) or “yellow-fat” (cattle, horses) animals according to their ability to 
accumulate carotenoids in their adipose tissue. Those in the first group hardly absorb carotenoids 
whereas the animals of the second group mainly absorb carotenes [182]. Ruminants accumulate 
β-carotene in the milk that is then transferred to dairy products [183]. Interestingly, both 
carotenes and xanthophylls (e.g. lutein) can be found in the human milk [184], but the possible 
beneficial roles of lutein in our early life are only beginning to be investigated [185]. Other 
animals such as birds or amphibians absorb mainly xanthophylls [182]. For example, lutein and 
zeaxanthin are commonly found in egg yolks from hens [186]. Birds also accumulate carotenoids 
in their plumage as a social interaction display [187]. The distinctive colors of many edible fish 
(salmon, trout), mollusks (mussel, clam), and crustaceans (shrimp, lobster) are also due to 
carotenoids (in some cases found as carotenoproteins) [188]. Carotenoids with diverse chemical 
structure (lutein, zeaxanthin, β-cryptoxanthin, canthaxanthin, astaxanthin, citranaxanthin 
capsanthin, β-apo-8’-carotenal, β-apo-8’-carotenoic acid ethyl ester) are widely used in animal 
feeds for pigmentation of dairy products, egg yolk, and several aquaculture fish [29, 188, 189]. 
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2.3. Carotenoid cleavage products  
Virtually all living organisms are able to catabolize carotenoids not only by non-enzymatic 
and unspecific reactions such as lipoxygenase cooxidation or photooxidation [190] but also by 
enzymatic oxidative breakdown [191, 192]. It is important to note that, despite the term 
“apocarotenoid” is often used to refer to all carotenoid cleavage products, only a fraction of 
these degradation products are actual apocarotenoids. For consistency, we will use the acronym 
CCPs for carotenoid cleavage products in general and only use the term apocarotenoids for 
carotenoid products that lost fragments at one or both ends of the molecule. In plants, CCPs can 
undergo further modifications (such as oxydations, reductions, cyclizations, methylations, or 
glycosylations) to render biologically active molecules. In many cases, cleavage of the carotenoid 
molecules results in volatile products or new water-soluble pigments. CCPs can also act as 
defense compounds against herbivores and pathogens, e.g. repellents or chemoattractants, as 
signals for predation and seed dispersal, as allelochemicals providing competitive advantages, as 
mediators of symbiotic associations, and as phytohormones, e.g. ABA and strigolactones [40, 190, 
193-199]. In addition, unknown carotenoid-derived molecules appear to regulate different 
developmental processes in plants [40, 198]. For example, the BYPASS signal is an 
uncharacterized graft-transmissible metabolite that functions as a negative regulator of both root 
and shoot growth [200, 201]. Root and leaf development are also controlled by unknown 
compounds derived from carotenoids [202, 203]. Plant CCPs also have an important impact in 
human health. The health promoting properties of apocarotenoids from saffron (Crocus sativus) 
and bixa (Bixa orellana) have been known for a long time [204, 205]. Several reports have shown 
that ABA is present and functionally active in humans [206], whereas strigolactones may have 
anti-cancer activity [207, 208]. Screening of aroma compounds revealed a cancer 
chemopreventive potential for volative CCPs such as β-ionone and members of the damascone 
group [209]. 
The enzymes catalyzing the oxidative cleavage of carotenoids to form CCPs are known as 
carotenoid cleavage dioxygenases (CCDs). These enzymes, which also recognize and cleave CCPs, 
are non-heme iron-containing enzymes with a common basic architecture consisting of a rigid 
seven-bladed β-propeller which forms a long tunnel on the central axis of the protein where the 
reaction center is located [210]. CCDs normally catalyze the cleavage of non-aromatic double 
bonds in the polyene chain by oxygen (O2) to yield aldehyde or ketone compounds [211, 212]. 
They are typically encoded by multigene families in bacteria, fungi, plants and animals [213]. The 
first CCD was identified in the ABA-deficient maize mutant Vp14 [214] and named as 9-cis-
epoxycarotenoid dioxygenase (NCED) [215]. Since then, homology-based searches have led to the 
isolation and characterization of many other enzymes involved in CCP biosynthesis [40, 213]. Two 
main subfamilies of CCDs are found in plants: NCEDs (exclusively involved in ABA biosynthesis 
and localized in plastids) and CCDs (not involved in ABA production). The CCD enzymes (CCD1, 
CCD2, CCD4, CCD7 and CCD8) differ in their subcellular location, regulation, substrate specificity 
and cleavage activity. As a consequence, despite starting from a limited number of carotenoid 
substrates they give rise to a vast range of CCPs with diverse functions (including hormones, 
signals, and volatile/flavor compounds).  
The sites recognized and cleaved by particular CCD enzymes are shown in Figure 8. CCD7 
and CCD8 act sequentially for the production of the strigolactone precursor carlactone [199, 
216]. The initial substrate is 9-cis-β-carotene, synthesized from β-carotene by the carotenoid 
isomerase DWARF27 [216-218]. The Arabidopsis thaliana CCD1 enzyme was initially found to act 
on a variety of carotenoids at their 9-10 and 9′-10′ double bonds [219], although further studies 
showed a relaxed double bond specificity [220]. In maize, CCD1 transcript abundance negatively 
correlates with carotenoid content in the grain endosperm [221-223]. By contrast, manipulation 
of CCD1 activity alters CCP levels [224] but not the carotenoid content of the other plant tissues 
[220, 225, 226]. These features, together with the cytosolic localization of the enzyme, led to 
suggest that CCD1 enzymes might not cleave intact carotenoids but act as scavengers of mixtures 
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of CCPs of different chain lengths and generate new bioactive CCPs with yet unknown functions. 
Closely related to CCD1, the plastid-localized CCD2 enzymes have only been found in Crocus 
species [227, 228]. CCD2 catalyzes the cleavage of zeaxanthin to produce crocetin and 4-hydroxy-
2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde. These two CCPs likely act as signals to attract 
pollinators and seeds dispersers [229] but they also display important pharmacological properties 
[204]. The CCD4 subfamily, the largest CCD subfamily in plants [213], shows a diversity of 
cleavage reactions and expression patterns [229-234], including the same enzymatic activity 
displayed by CCD2 in Crocus species [235]. Thus, CCD4 activity has been associated with the 
production of flavor volatiles and colored CCPs but also with carotenoid recycling during leaf 
senescence and seed desiccation [236], stolon development [237], and chloroplast biogenesis 
[202].  
 
3. Crop biotechnology  
Over the last three decades, many genes involved in carotenoid biosynthesis, storage and 
degradation have been cloned and some of them used to alter the carotenoid contents of crops. 
Carotenoid engineering strategies involve direct interventions to boost the accumulation of 
target carotenoids by (1) increasing flux through the pathway via overexpression of rate-limiting 
enzymes to relieve metabolic bottlenecks; (2) suppressing competing pathways downstream of 
branch points to avoid intermediates being diverted; (3) creating carotenoid sequestering 
structures and improving plastid sink capacity to store carotenoids; or (4) suppressing catabolic 
steps so that target carotenoids are not degraded or converted into undesired CCPs. Carotenoid 
engineering can also be used to produce carotenoids that are not naturally made in crops 
because the corresponding metabolic steps are missing. These include commercially important 
ketocarotenoids such as astaxanthin (Figures 5 and 6) and canthaxanthin (Figure 2). In this 
section we will briefly review major progresses in the metabolic engineering of carotenoids in 
different crops. The development of cultivars with elevated carotenoid content using classical 
breeding has been extensively reviewed elsewhere [238, 239] and will not be covered here. 
 
3.1. Leaves and roots 
3.1.1. Tobacco (Nicotiana tabacum) and related species 
Since the demonstration that plant leaves could be used to produce non-native 
ketocarotenoid pigments such as astaxanthin [240-242], many efforts have been focused on 
diverting the endogenous carotenoid pathway of several plants towards the biosynthesis of 
ketocarotenoids in their leaves. Perhaps the most outstanding examples include the generation 
of transplastomic lines and nuclear transformants of N. tabacum and the nicotine-free tobacco 
tree species N. glauca [243-245]. Transplastomic tobacco (N. tabacum) plants harboring codon-
optimized genes from the marine bacterium Brevundimonas encoding β-carotene ketolase (crtW) 
and β-carotene hydroxylase (crtZ) produced up to 5 mg/g DW of astaxanthin, reaching more than 
0.5% dry weight [243]. More than 70% of total carotenoids were transformed into 
ketocarotenoids in leaves, turning their green color into reddish-brown [243]. The same two 
genes have also been overexpressed in transgenic potato [246] and N. glauca [245] via 
Agrobacterium-mediated transformation. However, ketocarotenoid levels present in these lines 
were not as high as those found with transplastomic tobacco (N. tabacum) lines [243]. Using a 
similar strategy, a synthetic operon consisting of the Brevundimonas crtW and crtZ genes 
together with a plant LCYB-encoding gene was inserted into the tobacco (N. tabacum) chloroplast 
genome [244]. Astaxanthin accumulation in young leaves reached 10 mg/g DW (i.e. 1% of the dry 
weight of the plant), levels that are 2-fold higher than those maximally achieved in the previous 
attempt [243]. Most interestingly, the transformed chloroplast genome was then allowed to 
move from N. tabacum into N. glauca by grafting, a procedure that facilitates horizontal genome 
transfer between plants and thus provides a straightforward method for extension of the 
transplastomic technology to new species. The pigment profiles in leaves of transplastomic N. 
16 
 
glauca trees expressing the synthetic pathway were very similar to those found in N. tabacum 
[244]. In N. glauca flowers, which are normally yellow due to the accumulation of carotenoids 
such as lutein [241, 242], expression of the astaxanthin operon resulted in deep-orange petals, 
indicating conversion of the floral carotenoid pool. Transplastomic N. glauca flowers, however, 
still accumulated significant amounts of non-astaxanthin carotenoids, most likely because of the 
much lower activity of plastid gene expression in non-green tissues [244]. 
 
3.1.2. Lettuce (Lactuca sativa) 
Lettuce is a vegetable whose leaves synthesize a rare ε,ε-carotenoid, lactucaxanthin. With 
the goal of producing novel ketocarotenoids in the leaves, transplastomic lettuce plants were 
generated that expressed three codon-optimized genes from marine bacteria: crtW and crtZ from 
Brevundimonas sp. and IDI from Paracoccus sp. [247]. The transplastomic plants mainly produced 
astaxanthin fatty acid esters (67.4 % of total carotenoids), free astaxanthin (10.0 %) and other 
ketocarotenoids (17.5 %). The artificial ketocarotenoids corresponded to 94.5 % of total 
carotenoids [247].  
 
3.1.3. Carrot (Daucus carota) 
Carrot roots provide an important source of dietary β-carotene and α-carotene. Promoting 
the metabolic flux to carotenoids by overexpressing genes encoding DXS [248] or PSY [249] 
successfully increased the production of carotenoids in transgenic roots. Both total carotenoid 
and β-carotene levels also increased in transgenic carrots constitutively overexpressing the 
endogenous LCYB1 gene [250]. In this case, transgenic lines showed higher levels of the 
endogenous PSY2 gene (but not the PSY1 gene), which probably contributed to raising the total 
carotenoid level in roots [250]. Constitutive overexpression of the carrot LCYB1 gene in tobacco 
(N. tabaccum) resulted in increments in β-carotene and total carotenoids, increased expression 
of endogenous DXS2, PSY1 and PSY2 genes, and, surprisingly, a concomitant increase in plant 
height and biomass [251]. Changes in the expression of endogenous carotenoid-related genes 
were also observed in transgenic carrot plants overexpressing genes encoding Arabidopsis DXS 
[248] or H. pluvialis β-carotene ketolase [252]. In the latter, up to 70% of total carotenoids were 
converted to novel ketocarotenoids, reaching up to 2400 μg/g DW in the root. Astaxanthin, 
adonirubin, and canthaxanthin were most prevalent, followed by echinenone, adonixanthin and 
β-cryptoxanthin [252]. 
 
3.2. Fruits and tubers 
3.2.1. Tomato (Solanum lycopersicon) 
Tomato products are the principal dietary sources of lycopene and a major source of β-
carotene. As PSY activity is crucial to control the carotenoid pathway during tomato fruit 
ripening, it was early selected as a prominent target for the genetic engineering of the carotenoid 
content of tomato fruit. The first constitutive expression of a PSY-encoding gene in tomato 
resulted in carotenoid-rich seed coats, cotyledons and hypocotyls [253]. However, transgenic 
plants showed a dwarf phenotype because GGPP was diverted to the carotenoid pathway and 
hence became less available for the synthesis of the growth-promoting hormones gibberellins 
[253] (Figure 4). This work illustrated how problems arise when a balanced metabolism is 
disturbed. By using fruit-specific promoters, many of the problems associated with PSY 
overproduction in vegetative parts of the plant were circumvented. For example, fruit-specific 
expression of a bacterial PSY-encoding gene (crtB) resulted in up to 4-fold higher fruit 
carotenoids [61]. Upstream MEP pathway precursors are also rate limiting in tomato [254], so 
increasing the precursor supply can direct additional flux into the pathway thus increasing total 
carotenoid levels. This strategy was used in tomato, where the overexpression of the Escherichia 
coli gene encoding DXS resulted in a 1.6-fold increase in total fruit carotenoids [255].  
17 
 
Manipulation of the desaturation activity in tomato was achieved with a bacterial crtI gene 
encoding phytoene desaturase/isomerase [256]. While expression of this gene did not elevate 
total carotenoid levels in transgenic tomatoes, the β-carotene content increased about 3-fold to 
reach 45% of the total carotenoid content. Unlike PSY, which was down-regulated, the activity of 
endogenous carotenoid biosynthetic enzyme (PDS, ZDS, LCYB) was concurrently increased via 
upregulation of the expression of the corresponding genes. Similarly, expression of crtI in the 
tomato mutants tangerine (defective in CRTISO) and old gold crimson (ogc, defective in CYCB, the 
ripening-specific LCYB isoform) reduced the total carotenoid content in tomato fruits due to the 
downregulation of PSY activity [257]. Transgene expression resulted in the induction of CYCB in 
the tangerine mutant and LCYB in the ogc mutant [257], similar to a previous report [256]. Thus, 
transgenic tomato lines expressing crtI exhibited negative feedback mechanisms acting 
predominantly at the level of PSY and feed-forward mechanisms inducing cyclization [257]. 
Overexpression of a tomato LCYB gene resulted in high amounts of β-carotene (up to 205 μg/g 
FW) in the transgenic ripe fruits as a result of the almost complete cyclization of lycopene [258]. 
However, elevating β-carotene levels without reducing lycopene levels is more interesting for 
plant breeders. Two recent works have achieved this goal, resulting in tomato ripe fruits that 
were orange instead of red when ripe. In one of them, expression of a N. tabacum gene encoding 
LCYB driven by the Arabidopsis UBQ3 promoter resulted in enhanced levels of β-carotene in 
tomato fruit (up to 3-fold, 783 μg/g DW) with negligible changes of other carotenoids, including 
lycopene [259]. The second work investigated the activity of the fruit Clp protease during 
ripening [66]. Down-regulation of this protease disrupted normal chromoplasts differentiation 
and caused an increased accumulation of DXS and PSY enzymes but also of the Or chaperone, 
eventually resulting in ripe fruits with 2-fold higher levels of β-carotene but normal levels of 
lycopene [66].  
Tomato fruit is an excellent source to overproduce astaxanthin because sufficient 
precursors (lycopene and β-carotene) are available and the storage capacity for lipophilic 
carotenoids is high [260]. This was further improved by constitutive co-expression of 
Chlamydomonas reinhardtii β-carotene ketolase and Haematococcus pluvialis β-carotene 
hydroxylase, a unique pair of enzymes identified to co-operate in converting β-carotene to 
astaxanthin. Expression of the two enzymes in tomato up-regulated most intrinsic carotenogenic 
genes, and efficiently directed carbon flux into carotenoids, leading to massive accumulation of 
mostly free astaxanthin in leaves (3.12 mg/g DW) but esterified astaxanthin in fruits (16.1 mg/g 
DW) and a 16-fold increase of total carotenoid capacity therein without affecting plant growth 
and development [261]. This study opened up the possibility of employing crop plants as green 
factories for economical production of astaxanthin. More recently, ketocarotenoids were 
produced at high levels (3.0 mg/g DW) in tomato fruit expressing the Brevundimonas genes CrtZ 
and CrtW followed by β-carotene enhancement through the introgression of a CYCB-encoding 
allele from a Solanum galapagense background [262]. The predominant carotenoids were fatty 
acid esters of phoenicoxanthin, and scalability studies showed potential to deliver 23 kg of 
ketocarotenoid per hectare. Most interestingly, aquaculture trials demonstrated that the plant-
based feeds developed from these lines were more efficient than the synthetic feed to color 
trout flesh, showing up to 2-fold higher retention of the main ketocarotenoids in the fish fillets 
[262]. 
 
3.2.2. Orange (Citrus sinensis) 
Orange is a major crop and an important source of health-promoting bioactive compounds. 
Orange fruits accumulate a high amount of xanthophylls, especially β,β-xanthophylls. Through 
blocking the expression of an endogenous BCH-encoding gene involved in the conversion of β-
carotene into xanthophylls, signiﬁcant increase of β-carotene levels (up to 36-fold) were achieved 
in the pulp of sweet orange fruit [263].  
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3.2.3. Potato (Solanum tuberosum) 
Tubers are underground storage organs that can derive from stems (e.g. potato and yam) 
or roots (e.g. sweet potato and cassava). Potato tubers overexpressing a bacterial crtB gene 
accumulated total carotenoid levels up to 78 μg/g DW and β-carotene up to 6.5 μg/g DW [264]. 
Overexpression of a bacterial DXS-encoding gene resulted in total carotenoid levels of 6.8 μg/g 
DW, a 2-fold increase compared to untransformed controls [265], whereas co-expression of 
bacterial crtB, crtI, and crtY resulted in a significant enhancement of total carotenoid levels up to 
114 μg/g DW and β-carotene levels up to 47 μg/g DW [266]. Silencing of the endogenous LCYE 
gene by expressing an antisense RNA construct led to 14-fold more β-carotene (2.6 μg/g DW) 
compared to untransformed tubers, whereas total tuber carotenoids increased up to 2.5-fold (8.7 
μg/g DW) [267]. Another common target of specific enzyme inhibition is BCH, as this would 
prevent the conversion of β-carotene into zeaxanthin (Figure 4) and therefore force the 
accumulation of β-carotene as an end-product. Silencing of the corresponding potato gene 
increased β-carotene levels to 16.55 μg/g DW (a 331-fold improvement) and lutein to 6.85 μg/g 
DW (a 2.5-fold improvement), while zeaxanthin levels were reduced from 29 to 6 μg/g DW, a 
five-fold reduction [268]. In another successful example, the zeaxanthin content of potato tubers 
was enhanced by silencing the endogenous gene encoding ZEP [269]. This increased the total 
carotenoid levels by 5.7-fold (60.8 μg/g DW), β-carotene levels by 3.4-fold (2.4 μg/g DW), and 
zeaxanthin levels by 133-fold (40 μg/g DW). Proof of concept for the production of astaxanthin 
was achieved in potato albeit at low levels [270, 271].  
Carotenoid levels can also be modulated by creating a metabolic sink, i.e. promoting the 
formation of carotenoid-sequestering structures. Expression of the cauliflower Or gene [109] in 
potato confirmed that the protein induces chromoplast differentiation and carotenoid 
sequestration, resulting in a 6-fold increase in total carotenoids [110]. Furthermore, carotenoids 
in the generated transgenic lines remained stable for up to 6 months in cold storage leading to 
further accumulation, i.e. an 18-fold increase at 5 months and a 13-fold increase at 6 months 
[110, 272]. Co-expression of Or with bacterial crtZ and crtW genes improved astaxanthin 
accumulation in potato tubers up to 77 μg/g DW, 5.5-fold higher than previous attempts [271, 
273].  
 
3.2.4. Sweet potato (Ipomoea batatas) 
Sweet potato is an important tuberous root crop that produces low molecular weight 
antioxidants such as carotenoids and anthocyanins. Transgenic sweet potato plants constitutively 
overexpressing Or-Ins (endogenous Or insertion type) in an anthocyanin-rich purple-flesh cultivar 
exhibited up to 7-fold increased carotenoid levels in their tubers compared to untransformed 
controls [274]. The levels of zeaxanthin were 12 times higher in the transgenic plants, whereas β-
carotene increased 1.75 times. 
 
3.3. Oil seeds 
3.3.1. Canola (Brassica napus) 
Genetic engineering of canola seeds to boost their carotenoid content was a major 
achievement [275]. Overexpression of bacterial crtB using the seed-specific napin promoter 
increased total carotenoid levels to more than 1 mg/g DW, a 50-fold increase. While β-carotene 
accumulation reached 401 μg/g DW, the level of lutein remained unaltered [275]. The combined 
expression of bacterial crtB and crtI further increased total carotenoid levels to 1.4 mg/g DW with 
β-carotene levels reaching 857 μg/g DW [276]. In a more ambitious effort, seven bacterial 
carotenogenic genes were simultaneously introduced into canola [277]. Two of them encoded 
enzymes to increase GGPP supply (idi and crtE), three encoded enzymes to convert GGPP into β-
carotene (crtB, crtI, and crtY), and two more enabled ketocarotenoid biosynthesis (crtW and 
crtZ). Transgenic seeds expressing all seven transgenes accumulated up to 214 μg/g FW β-
carotene, a 1070-fold increase over wild type, and they also produced ketocarotenoids rarely 
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seen in plants, such as echinenone, canthaxanthin, astaxanthin, and adonixanthin [275]. On a 
different approach, downregulation of the endogenous LCYE gene in canola seed increased the 
levels of β-carotene, zeaxanthin, violaxanthin and, unexpectedly, lutein, achieving up to 41.7-fold 
higher concentrations of total carotenoids compared to untransformed seeds [278].  
 
3.3.2. Soybean (Glycine max) 
Expression of a recombinant sequence encoding pepper (Capsicum annuum) PSY and 
bacterial CrtI activities linked by a self-processed 2A peptide in Korean soybean (Glycine max L. 
cv. Kwangan) led to a 62-fold increase in total seed carotenoids (up to 146 mg/g DW), with 112 
mg/g DW (77%) of β-carotene [279]. Similarly to canola, transgenic soybean plants 
overexpressing a seed-speciﬁc crtB gene accumulated high levels (845 μg/g DW) of β-carotene 
[280]. When the crtB gene was introduced in combination with crtW to produce ketocarotenoids, 
the generated transgenic soybean seeds produced canthaxanthin at levels up to 52 μg/g DW 
[281]. Unlike untransformed seeds, which only produce lutein, transgenic seeds also accumulated 
other carotenoid compounds such as phytoene, lycopene, α-carotene, lutein, β-carotene, and β-
cryptoxanthin. Production of astaxanthin in transgenic soybean seeds has been shown to be 
possible [281] but accumulation levels were low (7 μg/g DW in the best line).  
 
3.4. Cereals 
3.4.1. Rice (Oryza sativa) 
The endosperm of cereal seeds is a major food staple, but it is deﬁcient in carotenoids. The 
β-carotene-rich Golden Rice was engineered by overexpressing plant PSY and bacterial crtI genes 
[282, 283]. However, carotenoids were found to degrade when Golden Rice was stored at 
ambient temperatures [284]. Thus, besides increasing the carotenoid content, another challenge 
is the proper storage and maintenance of nutritional qualities of the carotenoid-enriched rice. 
One of the genes responsible for degradation of carotenoids during storage is the lipoxygenase-
encoding gene r9-LOX1 which is also responsible for rice seed quality deterioration [285]. Down-
regulation of LOX1 activity in the β-carotene-enriched Golden Rice decreased oxidation of β-
carotene [285]. These results demonstrated that this is a key enzyme for catalyzing oxidation of 
β-carotene and that it has a signiﬁcant role in β-carotene degradation in rice. Recent efforts have 
also expressed Or in rice endosperm [112]. 
Proof of concept for the successful production of astaxanthin in Golden Rice was recently 
achieved by co-expressing sCrBKT, a synthetic C. reinhardtii gene encoding β-carotene ketolase 
[286]. The resulting grains accumulated predominantly the diketocarotenoids canthaxanthin and 
adonirubin as well as low levels of astaxanthin. The predominance of canthaxanthin and 
adonirubin indicated the presence of a hydroxylation bottleneck in the ketocarotenoid pathway. 
This final rate-limiting step must therefore be overcome to maximize the accumulation of 
astaxanthin, the end product of the pathway, in rice endosperm [286]. 
 
3.4.2. Maize (Zea mays) 
Transgenic maize endosperm expressing the bacterial crtB and crtI genes under the control 
of an enhanced γ-zein promoter resulted in increase of the total carotenoid content up to 33.6 
μg/g DW [287]. A significant advance was achieved with the development of a combinatorial 
genetic transformation system designed to dissect and modify the carotenoid biosynthetic 
pathway in maize, using the white endosperm elite South African inbred line M37W [288]. After 
randomly introducing into maize five carotenoid-related genes under the control of endosperm-
specific promoters, analysis of the resulting combinatorial transgenic maize plant population 
(equivalent to a “mutant series”) allowed the identification of rate-limiting steps in the 
endosperm carotenoid pathway and to recover maize plants with extraordinary levels of β-
carotene and other nutritionally important carotenoids [288]. The total endosperm carotenoid 
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content in an elite event (Ph3) co-expressing maize PSY1 and crtI reached 156 μg/g DW, including 
57 μg/g DW β-carotene and 26 μg/g DW lycopene. Simultaneous expression of a LCYB-encoding 
gene together with PSY1 and crtI in a different line (Ph4) dramatically reduced the levels of 
lycopene (11.50 μg/g DW, 7.73%) but increased the levels of zeaxanthin (34.53 μg/g DW, 23.21%) 
compared to the Ph3 line [288], confirming a rate-limiting role for LCYB in the synthesis of cyclic 
carotenes. Phytoene, which is absent in M37W endosperm, accumulated in Ph3, Ph4, and in a 
line (Ph1) expressing only PSY1 but not in the Ph2 line, which does not express PSY1, suggesting 
that the conversion of phytoene to lycopene is also a limiting step for carotenoid biosynthesis. 
Line Ph4 was used to introgress the transgenic PSY1-crtI-LCYB mini-pathway into a yellow maize 
inbred line with a high β:ε carotenoid ratio (A632), resulting in unprecedented amounts of 
zeaxanthin (56 μg/g DW) in the hybrids [289]. When the same mini-pathway was introgressed 
into a different yellow maize inbred with a low β:ε ratio (EP42), resulting hybrids had a very 
different carotenoid profile, with higher levels of lutein (23 μg/g DW) compared with the parental 
lines [289]. Silencing of the endogenous BCH1 and BCH2 genes in the endosperm of a range of 
maize genetic backgrounds led to up to 4-fold higher β-carotene content in all hybrids in which 
BCH2 was silenced, regardless of whether or not BCH1 was silenced too [290]. These and other 
results indicated that BCH2 is the main responsible enzyme for the conversion of β-carotene to 
zeaxanthin in maize endosperm [290]. 
The overexpression of Arabidopsis Or in the white-endosperm M37W line raised the total 
carotenoid content of the endosperm to 25 μg/g DW, a 32-fold increase, without changing the 
relative proportion of lutein and zeaxanthin [113]. Crossing the best-performing Or-
overexpressing line with four other transgenic parental lines accumulating different levels of 
carotenoids and/or ketocarotenoids yielded hybrids with the same qualitative carotenoid profiles 
as their parents. The total carotenoid levels in the hybrids increased when the carotenoid pool in 
the parent was restricted but there was no significant change when carotenoids were already 
abundant (above 70 µg/g DW) in the parent [113]. 
In early proof of concept experiments, limited astaxanthin accumulation in transgenic 
maize plants was attributed to a bottleneck in the conversion of adonixanthin (4-ketozeaxanthin) 
to astaxanthin [288]. More recently, transformation of M37W maize with constructs to 
overexpress PSY1, crtZ and sCrBKT and knock-down LCYE was successful to direct the pathway 
towards the production of astaxanthinin [291]. This astaxanthin-accumulating transgenic line was 
further crossed with a high-oil maize line (NSL76) in order to increase the storage capacity for 
lipophilic astaxanthin. The resulting hybrid line accumulated 60% of total seed carotenoids as 
astaxanthin, reaching levels of 16 μg/g DW [291]. 
 
3.4.3. Other cereals 
Sorghum (Sorghum bicolor) is deficient in β-carotene. The co-expression of genes encoding 
plant DXS and PSY enzymes with crtI in sorghum endosperm resulted in up to 10-fold increase of 
β-carotene, but with a half-life of less than 4 weeks [292]. Further co-expression of barley 
homogentisate geranylgeranyltransferase, however, significantly improved β-carotene 
accumulation and stability, extending its half-life from 4 to 10 weeks in sorghum grains [292].  
In order to enrich the carotenoid content in wheat (Triticum aestivum) grains, crtI was co-
expressed with PSY1 or crtB in wheat endosperm, resulting in a total carotenoid content of 5 
μg/g DW, a ca. 10-fold enrichment [293, 294]. Overexpression of crtB together with endosperm-
specific silencing of an endogenous BCH gene (TaHYD) was also successful to increase β-carotene 
content to 2.45 μg/g DW in wheat endosperm [295]. 
 
4. Nutrition and health 
A relevant property of carotenoids for human nutrition is their use as vitamin A precursors. 
Provitamin A activity, however, is restricted to carotenoids with at least one unsubstituted β ring, 
such as β-carotene (the most potent dietary precursor of vitamin A as it shows two unsubstituted 
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β rings), α-carotene, β-cryptoxanthin, and other carotenoids scarcely found in our diets (Figure 
4). Additionally, epidemiologic studies associate a carotenoid-rich diet (usually resulting from 
high consumption of fruits and vegetables) with health benefits. These beneficial properties of 
dietary carotenoids have stimulated an interest on carotenoid food sources, bioavailability and 
mode of action, as well as on their use in functional food and nutraceutical products. It is 
noteworthy, however, that only a fraction of the carotenoids ingested in our diet have been 
studied in depth, which means that there is much room to gain insight into the properties, 
actions and practical applications of dietary carotenoids. 
 
4.1. Health benefits  
Interest in carotenoids from a nutritional and physiological point of view has been 
focused mainly on the provitamin A activity of carotenoids containing β rings, as vitamin A 
deficiency is one of the major micronutrient deficiencies worldwide. In mammals, provitamin A 
carotenoids are converted into retinol and other related retinoids such as 11-cis-retinal and 
retinoic acid, which play important roles in the visual cycle and in gene regulation, respectively 
[296]. Additionally, carotenoids display other biological activities that may confer beneficial 
effects but whose relevance for human health is, in general, still uncertain [297-300]. Health-
related benefits associated with a high carotenoid intake include enhanced immune system 
functions and lower risk of developing degenerative chronic diseases, such as age-related 
macular degeneration, type 2 diabetes, obesity, certain types of cancer (breast, cervical, ovarian, 
colorectal), and cardiovascular diseases, among others [301-308]. Carotenoids are also attracting 
interest as promoters of cognitive functions [309-311] as well as skin photoprotectants and 
providers of cosmetic benefits, particularly in the context of the rapidly expanding nutricosmetics 
area [312]. Because carotenoids may undergo significant degradation and/or metabolism in the 
human body, it is far from certain whether the native compounds or rather their metabolites are 
responsible for the attributed health effects.  
Epidemiological data linking high carotenoid intake with improved health have inspired 
several intervention trials in humans which have emphasized that, while typical dietary intakes of 
carotenoids via fruits and vegetables appear to exert rather beneficial effects on health, 
supplemental intake with doses above 20 mg/d of purified or synthetic β-carotene may result in 
adverse effects, including increased cancer risk and total mortality [313]. The hypothesis that β-
carotene may decrease cancer risk was tested in the Alpha-Tocopherol Beta-Carotene (ATBC) 
trial, which included 29,000 participants who received a combined daily supplement of 20 mg/d 
of β-carotene together with other micronutrients for 5-8 years [314]. By the same time, this 
hypothesis was also tested in the Carotene and Retinol Efficacy (CARET) trial [315], which 
included ~18,000 participants who received a combined daily supplement of 30 mg/d of β-
carotene for 4 years on average. The ATBC and the CARET studies, where smokers and asbestos 
exposed subjects were supplemented with purified or synthetic β-carotene, surprisingly found 
increased, rather than decreased, lung cancer risk [315, 316]. The CARET study also reported an 
increased mortality due to coronary heart disease after β-carotene supplementation [315]. In 
both studies, β-carotene was given as supplements, resulting in much higher (up to 10 times 
higher on average) blood concentrations compared to the USA 95% percentile concentration 
[317]. The outcome of ATBC and CARET studies contrasts with a study with 22,000 non-smoking 
male physicians where the subjects were supplemented with 50 mg β-carotene every alternating 
day [318]. In this study, β-carotene supplementation did not result in any observed detrimental 
effects despite increasing β-carotene circulating levels [318]. Similarly, the Chinese Linxian 
intervention trial with 30,000 men and women, primarily non-smokers, reported preventive 
effects for stomach cancer and total mortality of a combined vitamin and mineral supplement 
including 15 mg/d β-carotene [319]. All these studies added to the controversy regarding 
carotenoid health benefits and safety, emphasizing that dosing, form of administration (food 
matrix or supplement), treatment duration, combination with other nutrients, and subject 
individual factors (e.g., healthy vs. sick, nutritional status) are likely important modifiers [296, 
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320]. In any case, the main take-home message is that dietary supplements of synthetic or 
purified carotenoids are not as effective in promoting health benefits as the intake of carotenoids 
in food products, where they interact with other cellular components. 
The interaction of carotenoids and retinoids with the control of lipid and energy 
metabolism in mammals is receiving an increasing attention due to its potential implications for 
chronic disorders including obesity, diabetes, nonalcoholic fatty liver disease and atherosclerosis 
[304, 321, 322]. A recent prospective study in 1042 nondiabetic Chinese adults found an inverse 
association between serum RA levels at baseline and the incidence of metabolic syndrome during 
a 4-year follow-up [323]. Evidence from animals and cell studies has accumulated that retinoids 
such as RA impact on developmental and biochemical processes influencing mammalian 
adiposity. Modulated processes include adipocyte differentiation, lipogenesis, adaptive 
thermogenesis, lipolysis, and fatty acid oxidation in tissues such as liver, white and brown 
adipose tissues, and skeletal muscle [321]. Retinoids effects on these processes converge in an 
overall anti-adiposity action. In line with these findings, expression of uncoupling protein 1 
(whose activity constitutes the molecular basis of adaptive thermogenesis) was promoted by 
carotenoids in cultured brown adipocytes, with an effectiveness that was related to their potency 
as retinoid precursors [324]. Furthermore, dietary β-carotene supplementation reduces adiposity 
in mice in a BCO1-dependent manner [325]. Other carotenoids with anti-adiposity activity in pre-
clinical models include β-cryptoxanthin, fucoxanthin and astaxanthin [304]. Importantly, anti-
adiposity action has been documented in pilot human intervention trials testing supplements 
enriched in these carotenoids [304].  
Among the non-provitamin A carotenoids, lutein and zeaxanthin deserve special 
attention as they are preferentially accumulated in the retina, together with meso-zeaxanthin, 
and they improve eye health. These three xanthophylls are collectively known as macular 
pigment, functioning as blue-light filters and as antioxidants that protect the retina from 
oxidative damage induced by light [326-330]. There is evidence of a protective role of lutein and 
zeaxanthin against age-related macular degeneration, a major cause of blindness in the elderly 
[326, 328, 331, 332]. Moreover, they also accumulate in brain tissue and there is increasing 
evidence that they provide cognitive benefits [309-311].  
 
4.2. Dietary sources 
4.2.1. Carotenoids in the diet 
Carotenoids present in food and feed products are usually C40, although some examples 
with shorter carbon number can also be found (including apocarotenoids and other CCPs). Most 
of the dietary carotenoids are obtained from a limited number of fruits and vegetables, but the 
contribution of animal-derived food should not be overlooked [308]. In fact, egg yolk, dairy 
products (milk, butter, etc.) and seafood contain high levels of carotenoids such as lutein, β-
carotene, zeaxanthin, astaxanthin, or canthaxanthin (see Section 2.2.5 above). Carotenoids can 
also be taken in the diet as food supplements or additives. In any case, our normal diet only 
covers a fraction of all carotenoid diversity. It has been estimated that our daily food intake only 
contains about 50 carotenoids that can be absorbed and used in our bodies [308]. In the human 
blood plasma, however, this number is reduced to around 20, from which the major ones are β-
carotene, α-carotene, β-cryptoxanthin, lycopene, lutein and zeaxanthin [333]. The largely ignored 
colorless carotenoids phytoene and phytofluene are also major circulating carotenoids [31]. 
Furthermore, a significant number of different geometric isomers for all these carotenoids have 
been reported [334].  
The presence and distribution of the most common carotenoid pigments found in generally 
consumed foods, mostly fruit and vegetables, are shown in Table 2. Most fruits and vegetables 
contain β-carotene, including carrots, red bell peppers, oranges, sweet potatoes, broccoli, and all 
green vegetables [308, 335]. The best sources of α-carotene are carrots, palm oil fruit and 
pumpkins, where it is always accompanied by β-carotene [308]. β-cryptoxanthin is widely found 
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at low concentration in fruits but it is a major carotenoid in ripe red and orange peppers, 
papayas, oranges, mandarins, mangos and persimmons [336-339]. Lutein is the major pigment in 
green vegetables such as spinach, Brussels sprouts, broccoli, and pea, whereas zeaxanthin is 
found in high concentrations in red pepper, goji berries, corn and egg-yolk [336, 340-342]. The 
main sources of lycopene are tomato fruits and derived products (pasta and sauces), together 
with watermelon and pink grapefruit [308, 343]. The benefits of carotenoids for human health 
have stimulated the search for new natural sources, including colorful exotic (tropical) and wild 
fruits and vegetables which may additionally supply other phytochemicals with nutritional 
properties and health benefits [344-348]. In parallel, selection and breeding of carotenoid-rich 
cultivars of traditional staple food crops such as potato or wheat will serve to enrich our diet in 
carotenoids and possibly other health-promoting phytonutrients [349-351].  
The green parts of plants (including leaves, stems, and green seeds and fruits) contain 
typical chloroplast-associated carotenoids. Besides lutein, β-carotene, violaxanthin, and 
neoxanthin, smaller amounts of α-carotene, -carotene, -cryptoxanthin, zeaxanthin, 
antheraxanthin and lutein 5,6-epoxide can also accumulate in these tissues. In some special 
cases, such as lettuce, an unusual dihydroxylated xanthophyll bearing two ε-rings 
(lactucaxanthin) is found. In contrast, non-green tissues of ripe fruits, seeds, and tubers have a 
highly diversified carotenoid profile depending on the species, the developmental stage, or the 
environmental conditions. Whereas xanthophylls are found free (non-esterified) in green leaves, 
they are esterified with fatty acids in many ripe fruits and some leaves and tubers [352-354]. In 
fact, xanthophylls esterified with fatty acids are the main carotenoid form in most fruits [352]. 
However, the presence of carotenoid esters has been often overlooked by many authors, mainly 
due to the use of saponification as a routine step in carotenoid analysis [355]. Consequently, 
information regarding carotenoid ester contents in fruits, vegetables and other plant materials 
(flowers, seeds and tubers) is scarce [24]. The acylation of xanthophylls with fatty acids seems to 
be an important part of the process used by plants to over-accumulate these pigments in 
carotenogenic fruits and senescing vegetables [354], enhancing and stabilizing their external 
color. This represents a vital role in attracting animals (including humans) to act as pollinators 
and seed dispersion vehicles [97]. The esterification of xanthophylls also appears to improve their 
stability against thermooxidative processes associated with food processing and to increase their 
bioavailability through a better solubilisation and extraction (bioaccessibility) during digestion in 
presence of dietary fat [356, 357].  
Besides genetic determination, the actual composition of carotenoids in plant products 
also depends on stage of maturity, variety or cultivar, harvesting season, production practices, 
post-harvest handling, processing and storage. Furthermore, differences among cultural and 
dietary habits, together with cooking, processing and preservation methods may profoundly 
affect the carotenoid content of foods. Heat treatments typically increase the chemical 
extractability of carotenoids (e.g. by softening membranes or cell walls), resulting in apparently 
higher levels of carotenoids in processed food compared to raw products [342, 358]. Another 
source of error is that the changes in the weight of the processed or cooked food are not taken 
into account, and so the reported retentions of carotenoids are not realistic. In this sense, several 
formulae for their calculation are recommended [358]. Processing, cooking and/or storage can 
also cause geometrical isomerisations [359, 360] and 5,6-epoxide to 5,8-furanoid re-
arrangements [17, 361] that are accompanied by changes in the light absorption spectra, hence 
explaining the noticeable food color changes that are often associated to these processes [358]. 
 
4.2.2. Classification of food sources  
As indicated above, the carotenoid content in foods depends on a great diversity of factors 
of different nature. Hence, the levels of carotenoids in a particular food can vary to a great 
extent. As a general guide, the carotenoid content of different food matrices has been compiled 
in several studies and databases such as the USDA Food Composition Database 
(https://ndb.nal.usda.gov/ndb) and others [335, 362-365]. The qualitative and quantitative 
24 
 
information gathered by such food composition databases provides a good hint on the type and 
amount of food supplying the adequate amount of a specific carotenoid. According to the criteria 
proposed by Britton and Khachik, the levels of a specific carotenoid in food products can be 
classified as low (0 – 0.1 mg/100 g), moderate (0.1 – 0.5 mg/100 g), high (0.5 – 2 mg/100 g) or 
very high (> 2 mg/100 g) [308]. Food sources with high or very high carotenoid levels include 
green vegetables, apricot, carrot, mango, palm oil, buriti and sweetpotato for β-carotene, 
persimmon, pitanga, papaya, pumpkin and tangerines for β-cryptoxanthin, green vegetables, 
pumpkin, sastra, and egg yolk for lutein, Chinese wolfberry, sastra, corozo, sapote, quince, 
orange and red peppers for zeaxanthin, or tomato, watermelon, red grapefruit and papaya for 
lycopene [308, 348].  
Five distinctive carotenoid patterns have been proposed in relation to the color of the 
plant tissue [308, 366]: (1) large amounts of the acyclic carotene lycopene, as in tomatoes (red 
color); (2) large amounts of β-carotene and/or its hydroxyl derivatives β-cryptoxanthin and 
zeaxanthin (orange color); (3) similar to pattern 2 but presenting also α-carotene and/or its 
hydroxyl derivatives, especially lutein (yellow-orange color); (4) large amounts of carotenoid 
epoxides (yellow color); and (5) carotenoids that appear to be unique to or characteristic of that 
species, e.g. capsanthin and capsorubin in red peppers (yellow, orange, or red color). Again, the 
carotenoid composition and, subsequently, the color vary in different cultivars. Some popular 
examples besides peppers are tomatoes (those containing lycopene as the major pigment are red 
but there are cultivars with orange fruits accumulating β-carotene or yellow fruits containing 
lutein) and carrots (orange when accumulating α-carotene and β-carotene but red or yellow 
when accumulating lycopene or lutein, respectively) [308]. Colorless phytoene and phytofluene 
have been largely ignored in the context of food science, but there is a growing interest for them 
in the fields of nutrition, health and even nutricosmetics [31]. High contents of these colorless 
carotenoids are found in tomato, carrot, apricot, red grapefruit, and red peppers [31, 342, 363].  
 
4.2.3. Dietary intake recommendations 
It is important to note that high carotenoid contents not always classifies a given food as 
a good contibutor to dietary carotenoid intake. Besides bioavailability issues (see Section 4.3 
below), the intake frequency is key to evaluate the main dietary contributors to the intake of the 
carotenoid [362]. Thus a food can have a very high content of a given carotenoid but can be 
scarcely consumed in the diet (e.g. exotic fruits in Western diets), whilst others can have a 
modest content but be taken very often (e.g. corn or bananas in certain countries). The total 
carotenoid intake in European countries (median values) ranges from ~9.5 to 16 mg/d (~3 to 6 
mg/d for β-carotene), being the major contributing food sources vegetables, followed by fruits 
and soups/bouillon [362, 367]. The carotenoid dietary intake from a selection of studies is shown 
in Table 3. The concentration of carotenoids in serum is considered to reflect short-term dietary 
intake and it is widely accepted as a good biomarker of fruit and vegetable intake [368, 369].  
No specific recommendations regarding the intake of carotenoids have been issued to 
date. Recommendation for provitamin A carotenoid intake for subjects not consuming other 
sources of this vitamin (e.g. animal sources) to fulfill its recommended dietary allowance (RDA) 
can be calculated as ~10.8 mg/d of β-carotene or twice as much (~21.6 mg/d) of other provitamin 
A carotenoids with only one unsubstituted β ring (Figure 4). This is expected to provide the RDA 
for healthy adult males and women: 900 and 700 µg retinol (vitamin A) activity equivalents per 
day, respectively. Although no RDA exists for lutein, there is increasing consensus that this 
carotenoid meets the criteria for non-essential bioactives regarding the promotion of optimal 
health and/or prevention of chronic diseases to be considered for intake recommendations 
[370]. Intakes of up to 10 mg/d of lutein and zeaxanthin have been advocated for some 
population segments [371]. In any case, recommendations for dietary carotenoid intake are 
impeded (1) by the fact that carotenoid bioavailability depends on a number of dietary as well as 
host-related factors that lead to inter-individual variability in absorption and metabolism [369], 
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and (2) by the scarcity of available information on the metabolic conversions of carotenoids in 
mammals. 
 
4.3. Bioavailability  
Bioavailability is defined as the fraction of a nutrient (e.g. carotenoid) that is absorbed and 
available for utilization in normal physiological functions or for storage [372, 373]. Carotenoid 
bioavailability is influenced by a combination of dietary and physiological factors and varies 
depending on the type of carotenoid, the food matrix in which the carotenoid is incorporated, 
and host-related factors [297, 372, 374]. Bioavailability encompasses other terms such as 
bioaccessibility, bioconversion, and bioefficacy. Bioaccessibility is the amount of the carotenoid 
released from the food matrix during digestion and made available for absorption. 
Bioaccessibility takes into account factors such as carotenoid species, food matrix, chemical state, 
amount ingested, and absorption modifiers, which can be studied by means of in vitro 
methodologies (including in vitro digestion, cellular and in silico models). These technologies are 
simple, low cost and reproducible, and they help to predict (to some extent) the bioavailability of 
food components [297, 374-376]. However, the information provided by bioaccessibility studies 
is incomplete as it does not include data on host-related factors, which hence need to be studied 
in vivo.  
Host related factors condition bioconversion and bioefficacy. For provitamin A carotenoids, 
bioconversion is traditionally defined as the proportion of absorbed carotenoid converted to 
retinol. Thus, a bioconversion rate of 100% means that all of the absorbed β-carotene is 
converted to retinal and then reduced to retinol (Figure 9). Bioefficacy is the efficiency with 
which ingested dietary carotenoids are absorbed and bioconverted to active retinol. A 100% 
bioefficacy means that all β-carotene taken in the diet has been absorbed and converted to 
retinol [377]. Host factors related to intra- and inter-individual differences in carotenoid 
absorption, distribution, metabolism and excretion have been thoroughly reviewed [297, 375]. 
The observed variability can be attributed to age, weight, disease state, physical activity, alcohol 
use, smoking habits, drug intake, or genetic aspects, but also to microbiota, factors influencing 
absorption such as parasites, or concentration of enzymes and other components involved in 
digestion [369].  
 
4.3.1. Estimating bioaccessibility in vitro 
In vitro methods to determine bioaccessibility attempt to mimic physiological conditions in 
vivo, simulating the digestion processes. They typically include the oral, gastric and small 
intestine phases, and, occasionally, large bowel fermentation. In vitro digestion models coupled 
with Caco-2 cells are also used in this assessment [374, 378, 379]. Models of simulated digestion 
process that mimic the peristaltic movements and body’s temperature are also available [380]. 
However, the majority of the models and methods reported in the literature are static. While 
they take into account the presence of digestive enzymes, pH, digestion time and salt 
concentrations, among other factors, they vary widely in the use of those parameters, making it 
quite difficult to compare results [376, 381]. A standardized digestion method, with conditions 
and composition of digestive fluids supported by a broad consensus in terms of physiological 
relevance, was recently published [381]. This consensus method was adapted to assess the 
bioaccessibility of provitamin A carotenoids in fruits, showing a similar or higher β-cryptoxanthin 
bioaccessibility than that of β-carotene in the fruits analyzed [382].  
 
4.3.2. Estimating bioavailability in vivo 
Bioavailability usually refers to in vivo studies in animals, the gold standard being the 
studies in humans. Among the latter, those most frequently used are short-term interventions 
(that is, single-dose, pharmacokinetic studies) and long-term interventions (involving repeated 
doses). In human intervention studies, different aspects regarding the subjects, methods, 
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biomarkers, and statistical analyses are crucial and need to be properly documented for a reliable 
and precise information on host-related factors and to allow the comparison among studies. The 
research question has to be clearly identified and the subjects well characterized (e.g. 
inclusion/exclusion criteria, representative sample, nutritional status). The methods should 
include clearly defined outcomes and adequate, valid and reliable markers. Markers for 
carotenoid bioavailability can be broadly divided into direct or biochemical markers (that usually 
refer to biochemical indicators of intake and/or status) and, indirect or physiological indicators 
(that should reflect cumulative exposure, biological effect or modification of risk factor) [383]. 
Finally, the study design and type of outcome indicators should be subjected to appropriate 
statistical analysis. Information should be included on all the variables known to have a possible 
influence on carotenoid metabolism (e.g. as inclusion criteria or as variables that could be used in 
the statistical analysis of the results).  
Another way to determine bioavailability is by using data from food intake and serum 
carotenoid levels. The blood carotenoid concentration in each individual (an indicator of the 
absorption capacity and corporal retention of the carotenoid) is divided by its corresponding 
intake, allowing to assess the apparent bioavailability. In the case of provitamin A carotenoids, 
current assumptions about retinol activity equivalent (RAE) provided for different dietary 
carotenoids are mainly based on data on β-carotene bioavailability and on the theoretical 50% 
yield of carotenoids with a single β ring such as α-carotene and β-cryptoxanthin [384]. But there 
is a wide variation in bioconversion factors (on a weight basis) for dietary β-carotene to retinol 
assessed in human studies, which is in the range from 3.6:1 to 28:1, with Golden Rice and leafy 
vegetables, respectively [320]. On the comparison of results from these studies, special attention 
has to be paid to factors such as the food matrix (e.g. fruits, vegetables, complete meal, isotope-
labeled food), amount ingested (higher intakes lead to lower conversion rates), characteristic of 
the subjects (e.g. with normal or marginal vitamin A status), and methods to assess the 
conversion (e.g. area under curve responses, changes of serum retinol concentration, changes of 
total body stores of vitamin A). The bioconversion of β-carotene into retinol is highly influenced 
by the food matrix, and the rate seems to be higher in fruits than in green vegetables. 
Interestingly, the apparent bioavailability of β-cryptoxanthin from typical western diets (mainly 
present in fruits as ester forms) appears to be greater than that of α-carotene or even β-carotene 
[339, 385].  
 
4.4. Absorption 
The absorption and metabolism of carotenoids (particularly β-carotene) in mammals has 
been addressed in detail in several reviews [386-391] and it is briefly summarized here. Early 
after ingestion of food, mastication, gastric action and digestive enzymes release carotenoids 
from the food matrix. Since carotenoids are nonpolar lipid compounds that cannot dissolve in 
aqueous solutions, they are incorporated in the stomach into mixed micelles consisting of lipids 
and bile components to be delivered to the apical surface of the enterocytes, the absorptive 
epithelial cells of the small intestine. The amount of carotenoid incorporated into micelles 
depends on the polarity of the carotenoid and on micellar lipid composition and saturation. 
Recently, it has been demonstrated that the geometry of the molecules can be even more 
important than polarity. Thus, the colorless carotenes phytoene and phytofluene, whose shapes 
are less rigid for having much fewer conjugated double bonds and being in a cis configuration, 
are much more efficiently released from different juices than major xanthophylls occurring in 
them [392].  
Non-provitamin A carotenoids (lycopene, lutein, zeaxanthin) can be absorbed intact or 
undergo oxidative cleavage before absorption from the intestinal lumen. Lutein and zeaxanthin 
esters (common in fruits and vegetables) are also hydrolyzed by pancreatic lipases in the lumen 
of the small intestine before their uptake [393]. Then, carotenoids are absorbed in free 
(unesterified) form by the enterocyte (mainly in the duodenum) via passive diffusion or through 
facilitated transport via scavenger receptor class B member 1 (SR-BI) and possibly other lipid 
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transporters, such as CD36. Once taken by the enterocytes, carotenoids are incorporated into 
large lipoprotein particles (nascent chylomicrons) for secretion [394], or can undergo enzymatic 
cleavage (Figure 9). Retinol derived from dietary β-carotene undergoes esterification to long-
chain fatty acids, and is also packaged as retinyl esters in nascent chylomicrons [387]. The 
efficiency of intestinal β-carotene cleavage varies greatly across species. Adult rats and mice are 
considered efficient cleavers that convert most absorbed β-carotene into retinol. However, even 
following mild acute or chronic oral β-carotene supplementation, some β-carotene is absorbed 
intact in adult rodents, as revealed by accumulation in tissues [325, 395]. In young (suckling) rats, 
absorption of intact β-carotene occurs even at lower dietary doses, probably due to their 
immature intestine [396]. In humans and other species such as horses and ferrets about 17%-
45% of the ingested β-carotene escapes intestinal cleavage, is incorporated into chylomicrons 
and is found associated with circulating lipoproteins. Interestingly, intestinal β-carotene 
absorption and cleavage are dependent on the animal’s vitamin A status through a feedback 
mechanism [397].  
Chylomicrons with their packaged carotenoids and retinyl esters are released by 
exocytosis to the lymphatic system for delivery to the bloodstream and eventually directed to the 
liver. Before reaching this organ, partial degradation by the activity of the endothelium-
associated lipoprotein lipase (LPL) causes liberation of part of the lipid content of the particles, 
including carotenoids. Most carotenoids reach the liver in chylomicron remnants. There, they are 
stored or secreted back into the bloodstream associated with very low density lipoproteins 
(VLDL). VLDL are converted into intermediate-density lipoproteins (IDL) and low-density 
lipoproteins (LDL) after being processed by LPL in the extrahepatic capillaries and exchange 
components with other lipoproteins. In the fasting state, most plasma carotenoids are associated 
with LDL and, to a lower extent, with high density lipoproteins (HDL). HDL particles are produced 
in the liver and intestine and are secreted into the blood and lymph, respectively. Carotenoids 
associated with HDL may therefore derive from the liver, directly from the gut, or from exchange 
between lipoproteins [398]. Apolar carotenoids such as lycopene and β-carotene are found 
mostly associated with LDL, whereas lutein and zeaxanthin are more evenly distributed between 
LDL and HDL fractions. A reason for this distribution might be that lycopene and β-carotene are 
mainly found in the core of the lipoprotein, whereas the more polar xanthophylls are mainly 
located on the surface. Therefore, transfer between lipoproteins might be easier for lutein and 
zeaxanthin, resulting in a more equal balance between LDL and HDL. As illustrated in Figure 10, 
carotenoids and retinyl esters contained in circulating lipoproteins are taken up by tissues 
through the action of lipoprotein-specific receptors, such as SR-BI (the receptor for HDL), LDL 
receptor (LDLr), LDLr-related protein-1, or LPL [389]. Membrane transporters may also be 
implicated, such as CD36, which mediates the uptake of lycopene by adipocytes [399]. Liver, 
followed by adipose tissue, kidney, skin and lung are important sites of accumulation of β-
carotene and other carotenoids [389]. In addition, there is a very specific deposition of lutein and 
zeaxanthin within the eye, suggesting a biological process governing their capture, deposition, 
and stabilization in the macula. This regulation or control is believed to be elicited by binding 
proteins [400]. 
Liver is also a major site for vitamin A storage, in the form of retinyl esters in stellate cells. 
Mobilization of vitamin A from hepatic stores depends on the 21-kDa retinol-binding protein 
(RBP, also known as RBP4), which is produced in hepatocytes and secreted into the circulation in 
a retinol-dependent manner. Circulating retinol-RBP complexes may be taken up by extrahepatic 
tissues or recycled back to liver multiple times. Uptake by cells relies on specific receptors of the 
retinol-RBP complexes (Figure 10). Extrahepatic organs such as the eye use the plasma 
membrane protein STRA6 (stimulated retinoic acid 6) as a high affinity RBP receptor for retinol 
uptake [401, 402]. STRA6 is also involved in mediating cellular responses to retinol-RBP 
complexes related to the activation of the JAK-STAT pathway [402, 403]. A second receptor de 
retinol-RBP is RBP receptor-2 (RBPR2), which is expressed primarily in liver and intestine and 
induced in adipose tissue of obese mice [404]. RBPR2 is structurally related to STRA6 and highly 
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conserved in vertebrates, including humans. Inside the cells, carotenoids and derived products 
are metabolized as described in the next Section. 
 
4.5. Metabolism in mammals  
Mammals possess at least two β-carotene cleavage enzymes: β-carotene-15,15′-
oxygenase (BCO1) and β-carotene-9’,10′-oxygenase (BCO2), which are expressed in the 
enterocytes and other tissues [390]. Studies in knockout mouse models indicate that BCO1 is the 
key enzyme for the production of retinoids with vitamin A activity from dietary β-carotene [405, 
406]. BCO1 cleaves β-carotene centrally into two molecules of retinal (also named 
retinaldehyde), which can be further oxidized irreversibly to retinoic acid (RA), or reduced 
reversibly to retinol (Figure 9). Lecithin:retinol acyltransferase (LRAT) and possibly other 
acyltransferases can esterify retinol to fatty acids for storage of retinyl esters (RE) in lipid droplets 
(Figure 10). Retinol can also be reversibly metabolized to retinal via alcohol dehydrogenases 
(ADHs) and retinol dehydrogenases (RDHs) (Figures 9 and 10). BCO2 cleaves β-carotene 
asymmetrically to generate diverse β-apocarotenals and β-apocarotenones (Figure 9). BCO1 can 
convert some BCO2 cleavage products, in particular -apo-10'-carotenal, into retinal [405]. BCO2 
products may also have biological activity on their own [387]. The two β-carotene cleavage 
enzymes further differ in their substrate specificity and cellular location. While BCO1 is specific 
for provitamin A carotenoids with at least one non-substituted β ring (such as β-carotene, α-
carotene and β-cryptoxanthin), BCO2 has much broader substrate specificity and metabolizes, for 
instance, the acyclic carotene lycopene and oxygenated carotenoids (i.e. xanthophylls, such as 
lutein and zeaxanthin) besides cyclic carotenes [390]. BCO1 is a cytosolic protein, whereas BCO2 
is localized to mitochondria (Figure 10), where it contributes to avoid harmful consequences of 
local carotenoid accumulation on mitochondrial function [407-409].  
Intracellular metabolism of carotenoids and derived products takes place with these 
metabolites bound to specific binding proteins (Figure 10), which may contribute to direct them 
to specific metabolizing enzymes and targets. Besides carotenoid binding proteins (CBPs), they 
include cellular retinol-binding proteins (CRBPs) as well as cellular RA binding proteins (CRABPs) 
and fatty acid binding protein 5 (FABP5), which deliver RA to specific nuclear receptors within the 
nucleus or to cytochrome P450 (CYP) enzymes for degradation [410]. Some of the components of 
the RA biosynthetic and catabolic machinery are regulated by RA itself, via feedback regulation 
loops. Although intracellular carotenoid metabolism in mammalian tissues is still poorly 
understood, it should be emphasized that BCO1 and BCO2 are expressed in many tissues, besides 
the intestinal mucosa. This widespread expression, together with the wide distribution of 
carotenoids within the body, has suggested that local tissue-specific conversion of carotenoids 
may contribute to the in situ generation of retinoids and other CCPs that may impact tissue 
metabolism and signaling pathways [390].  
 
4.6. Mode of action  
Besides specific cases such as that of macular pigments, which filter (or absorb) blue light 
and thus physically protect the underlying photoreceptor cell layer from light damage [330], 
common biological mechanisms of action may underlie the proposed health benefits of 
carotenoids. These mechanisms include (A) direct antioxidant and prooxidant activity, (B) 
activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway, (C) 
suppression of the nuclear factor B (NF-B) signaling pathway, and (D) interaction with other 
transcription factors, notably members of the nuclear receptor (NR) superfamily of ligand-
modulated transcription factors, among others [307, 411-415].  
 
4.6.1. Antioxidants and prooxidants 
Oxidative stress due to the accumulation of excess ROS has been related to malignant 
transformation of cells. Hence, antioxidants are usually viewed as preventive agents against 
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cancer development [416]. Carotenoids have direct antioxidant activity, i.e. radical quenching 
properties [411, 413, 414]. But while carotenoids are very efficient quenchers of singlet oxygen in 
simple solutions, their interactions in vivo are more complex as carotenoid aggregation or 
spanning of cell membranes can reduce their quenching efficiency. Carotenoids can also quench 
other free radicals to form carotene radicals with different properties from the original carotenes 
[417]. In the eye, lutein and zeaxanthin act as light filters but also as antioxidants to protect 
against the formation of ROS [327, 328].  
Carotenoids can also be prooxidant in cells under certain conditions, e.g. when highly 
reactive carotenoid breakdown products (including aldehydes such as retinal and epoxides) 
formed in the course of antioxidant action accumulate, or when carotenoid detoxifying 
mechanisms are compromised [418-420]. Studies in BCO2-deficient mice indicate that 
carotenoids in excess, if not properly detoxified through BCO2 activity, accumulate in 
mitochondria and induce oxidative stress leading to mitochondria dysfunction and subsequent 
activation of the intrinsic apoptotic pathway [407, 409]. In addition, carotenoids may have 
antioxidant or prooxidant properties depending on the type of radical involved in damaging 
effects, as seen for β-carotene in lung epithelial cells with chemical induced genotoxicity [421]. 
Importantly, prooxidant activity can be beneficial under certain circumstances. Increased ROS 
production can protect from cancer development by increasing the oxidative stress/damage 
response leading to apoptosis of the damaged cells [416]. In fact, the increase in ROS production 
induced by carotenoids such as β-carotene and lycopene in human colon adenocarcinoma and 
leukemia cells is highly coincident with their ability to induce apoptosis and cell cycle arrest [418, 
422]. It might be added that reduction of ROS by antioxidants can lead to the survival of 
preinitiated tumor cells [423]. Likewise, the increased administration of antioxidants during 
cancer progression and treatment may increase the cancer cell survival rate by enhanced 
resistance against oxidative stress and decreased apoptosis [424]. Thus, both antioxidant and 
prooxidant activities of carotenoids might be of interest in cancer, and the effects of carotenoid 
administration could differ depending on the stage of malignant transformation.  
Antioxidant as well as antiinflammatory activities of carotenoids or their derivatives 
might also be of relevance in regard to obesity, as obesity entails the development of oxidative 
stress and inflammation in adipose tissue [425, 426]. Many components of the classical 
inflammatory response, such as the induction of proinflammatory cytokines and macrophage-
attractant signals (chemokines), are activated in the obese adipose tissue. Adipose tissue 
oxidative stress and inflammation are thought to play a major role in the onset of insulin 
resistance [427, 428]. These cascades could be interrupted by carotenoids and carotenoid 
derivatives. In fact, there is evidence that RA and carotenoids such as lycopene and fucoxanthin 
and their metabolites inhibit proinflammatory cytokine and chemokine expression in cultured 
adipocytes and adipose tissue under inflammatory conditions [304, 429, 430]. Likewise, 
mechanisms of action of lutein and zeaxanthin in relation to cognitive function, though not fully 
elucidated, may relate to their antioxidant and anti-inflammatory capacities among others [311, 
414].  
 
4.6.2. Activators of the Nrf2 pathway 
Besides ROS scavenging, there is increasing awareness that carotenoids, or their polar 
degradation products or metabolites, may indirectly elicit antioxidant activity in cells through the 
activation of the Nrf2-dependent antioxidant response (Figure 10). In normal conditions, Nrf2 is 
associated with Kelch-like ECH-associated protein 1 (Keap 1), a cytoplasmic repressor of Nrf2 that 
serves as a molecular sensor of intracellular redox status. Redox stress disrupts the Keap1-Nrf2 
interaction, allowing Nrf2 to translocate to the nucleus to ensure proper and timely expression of 
genes that are involved in cellular antioxidant defense or detoxification. There is evidence that 
lycopene and other carotenoids may exert anticancer effects by up-regulating cellular 
detoxification enzymes [412, 431-433]. Three lycopenoids (apo-10'-lycopenoic acid, apo-10'-
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lycopenol and apo-10'-lycopenal) were shown to activate the Nrf2-mediated induction of stress-
induced antioxidant and phase II detoxification enzymes in BEAS-2B human bronchial epithelial 
cells [434]. Similar results were obtained with aldehyde carotenoid derivatives [432].  
 
4.6.3. Suppressors of the NF-B pathway 
Carotenoids and carotenoid derivatives interact with the NF-B pathway to suppress NF-
B activation, thereby inhibiting the downstream production of inflammatory cytokines and 
disturbing NF-B-promoted cancer development [415, 435]. NF-B, similar to Nrf2, is normally 
bound to a cytoplasmic inhibitor (IB) from which it dissociates in response to a variety of stress 
stimuli (e.g. cytokines, free radicals, heavy metals, ultraviolet irradiation, oxidized LDL, bacterial 
or viral antigens). This allows NF-B to translocate to the nucleus to exert its transcriptional 
activity on inflammation-related genes. A possible unified explanation for the interference of 
carotenoids and/or carotenoid derivatives with the Nrf2 and NF-B pathways (Figure 10) is that 
they induce a certain degree of intracellular oxidative stress, leading to the oxidative modulation 
of sulfhydryl groups or phosphorylation status of Nrf2, NF-B or their interacting proteins [415, 
422]. For instance, it has been reported that apocarotenals contain electrophilic groups that can 
interact with the cysteine residues of IB kinase and NF-B, thereby suppressing NF-B activation 
[415]. 
 
4.6.4. Interaction with transcription factors 
The hydrophobic nature of carotenoids and their derivatives makes them good 
candidates for interaction with transcription factors of the NR superfamily (Figure 10), which bind 
ligands that easily transverse the cell membrane or lipophilic ligands generated intracellularly. 
Indeed, RA isomers derived from β-carotene (or preformed vitamin A) are endogenous agonist 
ligands of specific NRs collectively termed retinoid receptors: the canonical RA receptors (RARs: 
,  and ) and the retinoid X receptors (RXR: ,  and ). The all-trans RA isomer (atRA) binds the 
RARs, whereas the 9-cis-RA isomer binds both the RARs and the RXRs. In a ligand-dependent 
manner, the retinoid receptors directly interact with the genome and modify transcription of 
specific genes, or interfere with the activity of other transcription factors such as activator 
protein-1 (AP-1) or CCAAT-enhancer binding proteins (C/EBPs) [321, 436]. Heterodimers of RAR 
with RXR control the expression of typical retinoid target genes in a manner that depends on 
atRA binding to the RAR moiety and subsequent recruitment of cofactor complexes to the gene 
promoter [436]. RXRs are obligate dimerization partners for many nuclear receptors besides the 
RARs, including peroxisome proliferator activated receptors (PPARs), liver X receptor, farnesoid X 
receptor, pregnane X receptor, thyroid hormone receptor and vitamin D receptor. Some RXR 
heterodimers respond to ligands of either partner and are synergistically activated when both 
ligands are bound, providing a mechanism for widespread effects of retinoids on gene expression 
[437]. Besides activating the canonical RARs, atRA (but not 9-cis-RA) might behave as an 
activating agonist ligand of PPAR/ but not the other PPAR isoforms, namely PPAR and PPAR 
[438], although conflicting results have been reported [439]. The intracellular RA binding proteins 
CRABP-II and FABP5 are thought to deliver atRA to RARs and PPARβ/δ, respectively [440]. Effects 
of retinoids on cell differentiation and proliferation are largely downstream their interaction with 
the retinoid receptors [441]. For instance, repression of the pro-proliferative transcriptional 
activity of AP-1 by retinoid-bound RARs is key to the effects of retinoids against 
hyperproliferative diseases [441]. Retinoid interaction with lipid and energy metabolism in 
animals is also largely dependent on retinoid ability to activate NRs [321]. 
Other CCPs besides RA can interact with NR transcription factors to either promote or 
antagonize their action on target genes (Figure 10) [304, 432]. For example, apo-10′-lycopenoic 
acid, a product of eccentric cleavage of lycopene, inhibits lung cancer cell growth in vitro and 
suppresses lung tumorigenesis in a mouse model in vivo. Linked to this antiproliferative activity, 
apo-10′-lycopenoic acid transactivated the RARβ promoter and induced the expression of RARβ, 
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which led to the proposal that apo-10´-lycopenoic acid may function as a RA analogue [442]. 
Further, apo-10'-lycopenoic acid was demonstrated to reduce the production of proinflammatory 
markers in adipose tissue and adipocytes through RAR transactivation [443]. Other CCPs, such as 
-apo-14'-carotenal, -apo-14'-carotenoic acid and -apo-13-carotenone (the three of them 
derived from eccentric cleavage of β-carotene), were shown to bind the RARs with high affinity 
and to antagonize the atRA-induced, RAR-dependent transactivation of target genes in cells of 
hepatic origin (HepG2) [444]. -apo-14'-carotenal was also shown to repress agonist-induced 
activation of PPARs, leading to the inhibition of adipose conversion of preadipose cells, which is 
PPAR-dependent [445]. Because some of these CCPs are contained in foods and found in human 
plasma, it has been proposed they may act as naturally occurring retinoid antagonists [387].  
Even intact carotenoid molecules appear to be able to interact physically with NRs. In 
vitro studies have suggested that -cryptoxanthin can behave as a RAR agonist ligand [446] and 
astaxanthin as a PPAR antagonist ligand [447]. RAR agonism and PPAR antagonism are both 
expected to inhibit adipogenesis of preadipose cells. In agreement, both -cryptoxanthin and 
astaxanthin have inhibitory effects on adipogenesis and anti-obesity activity in mouse models 
[304, 446, 447]. 
 
4.6.5. Other mechanisms 
There is evidence that retinoids may impact cell metabolism and cell-signaling pathways 
through extragenomic actions including retinoylation (acylation by RA) of proteins and activation 
of protein kinase cascades [321, 387, 415, 448-450]. It cannot be discarded that other carotenoid 
derivatives may act also in these ways. 
 
Conclusions and perspectives  
There is no doubt that our understanding of carotenoid biosynthesis and functions in 
microbes, plants and animals has greatly advanced in the last few years. New structural and 
regulatory genes have been identified, including those encoding ZISO, CCD enzymes responsible 
for the production of valuable pigments and volatiles, and other enzymes involved in 
strigolactone biosynthesis as well as transcriptional regulators of carotenoid biosynthesis in 
plants and bacteria. However, other biosynthetic steps (such as those involved in the 
isomerization and esterification of plant carotenoids or the formation of many microbial 
carotenoids) still remain elusive. New available multi-omics strategies should contribute to 
identify and characterize the genes and enzymes involved in these steps. Technologies are also 
available to discover new carotenoid-producing organisms from marine environments (such as 
archaea, bacteria, fungi, and phytoplankton) and to investigate the potential industrial 
applications of novel carotenoids that could be found or that are already known. Strikingly, the 
rules for the nomenclature of carotenoids were approved over 40 years ago and have hardly 
changed ever since. It appears necessary to revise and update the nomenclature rules to remedy 
possible problems such as those involving newly identified carotenoids with uncommon 
structures or those associated to acyl, sugar or other moieties. In relation to these latter 
carotenoids, it is important to consider that such associations do change considerably the 
properties of the “unmodified” carotenoid. Few studies on this respect exist despite the 
corresponding information might be very useful to open the range of practical applications of 
carotenoids. It is noteworthy that only a small fraction of the hundreds of carotenoids described 
so far are being studied in depth, which means that there is much knowledge to be gained into 
the properties, actions and practical applications of carotenoids. 
Strigolactones have been consolidated as a new class of plant hormones, but information 
regarding tissue-specific functions, transport, and perception of the different strigolactones 
produced by plants remain mostly unknown. Besides strigolactones, many CCPs of unknown 
identity have been reported as having signalling functions in plant development and 
environmental interactions. Research on carotenoid-related signals is actually one of the hottest 
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topics in the carotenoid field, not only in plants but also in animals and other organisms. 
However, progress is somewhat hindered for different reasons, including inconsistencies in their 
nomenclature (e.g. not all CCPs are apocarotenoids: ABA, strigolactones, or retinoids are not 
strictly apocarotenoids), scarcity of commercially available standards, and lack of extinction 
coefficients and absorption spectra. Future research should lead to the identification of the 
biologically active molecules and the characterization of their physicochemical properties and 
physiological functions. It would also be important to investigate their biosynthetic pathways and 
their compartmentalization, as well as the molecular mechanism implicated in their regulation. 
Similarly, more efforts should be made to understand the function and subcellular localization of 
carotenoids and their derived metabolites in non-photosynthetic microorganisms such as fungi. 
The discovery of carotenoid biosynthetic genes of fungal origin in several groups of 
animals, on the other hand, has challenged the previous dogma that animals do not produce 
carotenoids de novo, providing further examples of horizontal gene transfer as a mechanism to 
produce “natural transgenic organisms” with acquired new functions (i.e. the capacity to 
synthesize carotenoids). In the field of “artificial transgenic organisms”, the last years have 
witnessed major advances in carotenoid biotechnology in plants and bacteria. Proof of concept 
for the biotechnological overproduction of high added-value carotenoids such as astaxanthin has 
been achieved in many organisms, but our still limited knowledge of the endogenous regulatory 
networks influencing metabolic fluxes and interaction with related pathways is still a major 
drawback for obtaining commercially-relevant levels. For example, the paramount influence of 
light on the accumulation of plant carotenoids has been known for long time but the basic 
mechanisms by which light signals are transduced to eventually modulate the biosynthesis and 
accumulation of these important photoprotective pigments were only recently unveiled. In this 
context, it will be important to transfer and apply the information generated in model plants to 
agronomic crops. Available knowledge should also be useful to develop genetic markers for 
genomics-assisted breeding programs aimed to improve carotenoid content and composition in 
crops. Recovery of germplasm and traditional varieties (landraces) should further allow to 
understand carotenoid diversity and to identify genetic traits that determine carotenoid profiles, 
as well as the changes that occurred during domestication. Furthermore, the power of new 
technologies such as synthetic biology and genome editing (e.g. via CRISPR/Cas9) still awaits to 
be fully exploited in the field.  
Recent discoveries have also highlighted that sequestration and storage are central 
determinants of final carotenoid levels in plants. However, very little is known about the 
suborganellar structures involved in the sequestration and storage of carotenoids as well as the 
signals and mechanisms underlying their differentiation. In particular, the storage of carotenoid 
esters (very abundant in some plant tissues) represents an unexplored aspect in carotenoid 
research. Since the physicochemical properties of carotenoid esters highly differ from those of 
the corresponding free carotenoids, it is likely that they are stored in different plastidial 
compartments. This hypothesis, however, awaits experimental validation. In any case, plastids 
are much more than mere reservoirs of carotenoids, as they have a central role in controlling the 
activity of biosynthetic enzymes (many of which appear to be associated to carotenoid-rich 
membranes and plastoglobules) and the carotenoid profile at both qualitative and quantitative 
levels. We still know very little about where the enzymes of the carotenoid pathway are localized 
within plastids. The proposal that these enzymes can interact to form metabolic channels 
(metabolons) should be further investigated, as it opens the possibility of alternative regulatory 
mechanisms involved in carotenoid biosynthesis that have not yet been fully explored. 
Understanding the molecular mechanisms underlying plastid identity will be key to 
manipulate plant carotenoid contents in the future. To date, however, the Or chaperone is the 
only protein known to trigger the differentiation of carotenoid-accumulating plastids 
(chromoplasts). And even in this case, the functional roles of Or in plastids but also in the nucleus 
(where it has also been localized) remain far from clear. Future work should establish what is the 
specific molecular pathway connecting Or activity and chromoplast differentiation. Other 
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chaperones (such as ClpB3) and proteases (the Clp proteolytic complex) were recently shown to 
regulate the correct folding (and hence activity) and the stability of carotenoid biosynthetic 
enzymes. Besides coordinating carotenoid biosynthesis with the supply of their biosynthetic 
precursors, the Clp protease also appears to have a role in chromoplasts differentiation, further 
contributing to regulate the accumulation of carotenoids.  
The type of carotenoid storage structures in plastids can strongly influence carotenoid 
bioavailability. The number of carotenoids eaten in a varied diet is much larger than generally 
shown in food composition tables, and the study of carotenoid bioavailability should be extended 
to include such low-abundant carotenoids as well as xanthophyll esters, as they are the most 
common native state for hydroxy-carotenoids in many fruits. This is particularly relevant in the 
current context of searching and incorporating novel natural sources of carotenoids in the diet, 
mainly focused on exploiting the biodiversity of tropical regions, oceans and poles, as well as the 
use of underutilized plant species, cultivars or landraces. Furthermore, many dietary factors, as 
well as host-related factors, have been found to influence carotenoid absorption and metabolism 
in animals. There is an urgent need for standardized protocols to assess bioaccessibility of 
carotenoids (as well as their esters and derived products) in food matrices and for establishing 
RDA or adequate intake for individual carotenoids commonly present in our diets, such as β-
cryptoxanthin, lutein, zeaxanthin, and lycopene, among others. In the case of provitamin A 
carotenoids, assessment of their contribution to the dietary intake of vitamin A should be more 
clearly determined in light of the results of recent studies on bioavailability from different types 
of food matrices and chemical structures (carotene vs xanthophyll) and on the effect of 
polymorphisms in their conversion to vitamin A.  
The idea that carotenoids and their derived products have biological activities in humans 
other than provitamin A was also consolidated in the last years. The spectrum of health-related 
processes impacted by carotenoids and CCPs (including but not restricted to retinoids) in 
mammals is rapidly expanding. Besides the already known beneficial health effects of 
carotenoids for protection against photodamage, macular degeneration, and chronic diseases, 
new results are demonstrating a positive effect on preventing obesity and, particularly in the case 
of lutein, improving cognitive functions. Interaction with oxidative stress and inflammation 
pathways, and with NR-mediated signaling might explain many of these effects. However, the 
contribution of most dietary carotenoids (including those lacking color, such as phytoene and 
phytofluene) to human health remains virtually unknown. Whether the native compounds alone 
or rather their metabolites are responsible for the attributed health effects remains unclear. 
Furthermore, much is yet to be discovered regarding the regulated production and biological 
action of CCPs in animal tissues. Investigating the role and biological activities of catabolites 
produced from dietary carotenoids during digestion is expected to be a promising area of 
research for the near future. This is particularly important for carotenoids labelled as “non-
absorbed” and “non-bioavailable” such as violaxanthin and neoxanthin. Future research should 
also contribute to understand the biological mechanisms of action underlying the proposed 
health-related activities of carotenoids, eventually resulting in optimized suggestions for dietary 
intakes. 
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Tables 
Table 1. Bacterial genes and enzymes involved in carotenoid biosynthesis 
 
Gene Product (enzyme) 
crtA Spheroidene monooxyenase 
crtB Phytoene synthase 
crtC Hydroxyneurosporene synthase 
crtD Methoxyneurosporene desaturase 
crtE GGPP synthase 
crtF Hydroxyneurosporene-O-methyltransferase 
crtG β-Carotene 2-hydroxylase 
crtH Carotene isomerase  
crtI Phytoene desaturase (CrtI type) 
crtL Lycopene cyclase (CrtL type) 
crtL-b  Lycopene β-cyclase  
crtL-e, lcy-e Lycopene ε-cyclase  
crtM Dehydrosqualene synthase  
ctrN Dehydrosqualene desaturase, Diapophytoene desaturase 
crtO β-Carotene ketolase 
crtP Phytoene desaturase (CtrP type) 
crtQ ζ-Carotene desaturase 
crtR β-Carotene hydroxylase  
crtS Stress-responsive sigmaB-like protein 
crtT Methyltransferase-like protein 
crtV Methyltransferase-like protein 
crtU β-Carotene hydrogenase 
crtW β-Carotene ketolase, β-C-4-oxygenase  
crtX Zeaxanthin glucosylase 
crtY Lycopene cyclase (CrtL type) 
crtYc Lycopene cyclase  
crtYd Lycopene cyclase  
crtZ β-Carotene hydroxylase 
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Table 2. Common carotenes and xanthophylls in foods and natural sources. 
 
Type Carotenoid Natural occurrence 
Carotenes 
-carotene, -carotene, 
-carotene, -carotene,  
-carotene, -carotene 
Fruits and vegetables, especially in carrots, sweet 
potato, palm tree fruit.  
Rose hips are good source for -carotene. 
lycopene, neurosporene Tomato, water melon and rose hips. 
phytofluene, phytoene Carotenoid-rich fruits, flowers and carrot. 
Xanthophylls 
antheraxanthin Fruits and green vegetables. 
Anthers and petals of many yellow flowers.  
astaxanthin Fish (salmon) and crustaceans (e.g. lobster). 
bixin, norbixin Annatto (Bixa orellana) seeds. 
canthaxanthin Fungi, cyanobacteria and green algae. 
capsanthin, capsorubin Pepper ripe fruits. 
crocetin Saffron stigmas. 
cucurbitaxanthin A Pumpkin flesh. 
lactucaxanthin Lettuce leaves. 
lutein  Green fruits, vegetables, flowers and cereal 
grains (wheat). Also in egg yolk. 
violaxanthin, neoxanthin Green fruits, vegetables and flowers. 
luteoxanthin, auroxanthin, 
mutatoxanthin 
Vegetables and fruits processed under acid 
conditions and fermentation. 
rubixanthin Rose hips. 
zeaxanthin Corn, potatoes, red pepper. Also in egg yolk. 
-cryptoxanthin,  
-cryptoxanthin 
Seeds (corn), flowers and fruits: sweet orange, 
tangerine, mango, papaya, persimmon, pepper. 
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Table 3. Carotenoid dietary intake from a selection of studies, mean and/or [median]  
 
Sample (N), 
country 
Women / Men 
(age in years) 
Dietary intake (mg/d)* 
Reference 
α-car β-car β-cryp Lut/Zea Lyco 
N=117, USA W (29-39)  0.75 
[0.55] 
3.34 
[2.70] 
0.04 
[0.03] 
2.39 
[1.87] 
3.35 
[3.01] 
[1] 
N=547, USA 
 
346 W (67-93) 
 
201 M (68-91) 
0.86 
[0.56] 
0.66 
[0.44] 
4.21  
[3.74] 
3.52  
[2.90] 
0.08  
[0.05] 
0.06  
[0.05] 
3.09  
[2.52] 
2.68  
[2.30] 
7.00  
[5.65] 
7.64  
[6.40] 
[2] 
N=64, Ireland  
 
W (25-45) 
W (>65) 
M (25-45) 
M (>65)  
2.43 
1.22 
2.29 
1.21 
8.80 
5.50 
8.08 
5.28 
0.73 
0.32 
0.47 
0.30 
2.62 
2.12 
2.32 
1.88 
8.05 
4.62 
7.64 
2.03 
[3] 
N=280, USA W, M (18-50)   2.94  1.10 8.37 [4] 
N=75, France 
N=65, N. Ireland 
N=73, Ireland  
N=72, Holland 
N=64, Spain  
W, M (25-45)  
W, M (25-45) 
W, M (25-45) 
W, M (25-45) 
W, M (25-45)  
0.74 
1.04 
1.23 
0.68 
0.29 
5.84 
5.55 
5.16 
4.35 
2.96 
0.45 
0.99 
0.78 
0.97 
1.36 
2.50 
1.59 
1.56 
2.01 
3.25 
4.75 
5.01 
4.43 
4.86 
1.64 
[5] 
N=459, Costa 
Rica 
115 W (59±10) 
344 M (56±11) 
0.73 
0.45 
4.67 
3.41 
0.55 
0.38 
2.89 
2.41 
5.77 
5.45 
[6] 
N=59, USA W, M (65-87) 0.64 4.60 0.07 3.81 9.43 [7] 
N=98, USA  W, M (45-73)  4.48  1.79 8.29 [8] 
N=12741, France 
 
W(35-60) 
M (35-60) 
 3.96 
3.92 
   
[9] 
N=402, USA 
(African-American) 
247 W (34-84) 
155 M (34-84)  
[0.25] 
[0.33] 
[2.21] 
[2.21] 
[0.13] 
[0.11] 
[1.93] 
[1.85] 
[2.60] 
[3.16] 
[10] 
N=262, USA W, M 0.19 1.73 0.12 3.96 4.75 [11] 
N=470, USA a 
 
W (40-69) 
M (40-69) 
0.57 
0.50 
3.51 
2.91 
0.14 
0.13 
2.40 
2.17 
4.22 
5.64 
[12] 
N=159, Sweden W (56-75)  
 
1.03 
[0.65] 
3.47 
[3.07] 
0.46  
[0.33] 
2.64  
[2.5] 
2.15  
[1.91] 
[13] 
N=108, Spain 
 
54 W 
54 M 
54 (20-35) 
54 (45-65)  
   1.28 
1.05 
1.00 
1.34 
 
[14] 
N=50 , Dominican 
Republic 
W, M (22-69)  0.7 
[0.61] 
2.7  
[1.62] 
0.22 
[0.08] 
1.33 
[0.72] 
1.46 
[1.09] 
[15] 
N=91, Australia W (18-70) [2.0] [6.87]  [2.28] [5.05] [16] 
N=96335, USA & 
Canada a (25% 
African-American)  
W, M (50-90)  1.07 6.67 0.21 4.11 4.48 
[17] 
From National Surveys 
N=3000, Spain 
Years: 2009-2010 
W, M (18-64)  
    From total diet 
    From F+V intake 
 
0.27 
0.27 
 
1.46 
1.31 
 
0.32 
0.22 
 
1.24 
0.84 
 
3.06 
3.0 
[18, 19] 
N=55950, Brazil 
Years: 2008-2010 
W, M (≥ 10) 
    From F+V intake 
 
0.16 * 
 
0.92 * 
 
0.16 * 
 
0.83 * 
 
0.83 * 
[20] 
USA 
Years: 2009-2010 
W, M (≥ 20) 
    From total diet 
 
0.4 
 
1.9 
 
0.2 
 
1.4 
 
1.4 
[21] 
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* Dietary assessment method: food frequency questionnaire, except in [12]: diet history 
questionnaire; [11, 15, 18, 19, 21]: 24h dietary recall; [18, 19]: 3-day diet diary; [20]: 2-day 
records.  
a (mg/d): geometric mean 
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Figures 
 
 
 
Figure 1. Structural features of carotenoids. A, Numbering of carbon atoms in an acyclic 
(lycopene) and a cyclic (β-carotene) carotenoid. B, End groups present in carotenoid molecules. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Chemical structures of some carotenoids. Numbers in parentheses indicate the number 
of conjugated double bonds. Only phytoene and phytofluene are carotenes.  
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Figure 3. Chemical structure carotenoid isomers. A, Geometrical isomers of β-carotene. B, 
Optical isomers of zeaxanthin. Arrows mark S bonds.  
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Figure 4. Carotenoid biosynthesis and related isoprenoid pathways in plants. Carotenes are 
boxed in orange and xanthophylls in yellow. Xanthophyll cycles identified in plants are also shown 
(blue arrows represent the reactions induced by high light). The presence of unsubstituted β rings 
in provitamin A carotenoids is marked with green asterisks. Hormones are marked with circles 
(ABA, abscisic acid; BRs, brassinosteroids; CKs, cytokinins; GAs, gibberellins; SLs, strigolactones). 
Dashed lines represent multiple steps. GAP, glyceraldehyde 3-phosphate; MEP, methylerythritol 
4-phosphate; MVA, mevalonic acid; IPP, isopentenyl diphosphate; DMAPP, dimethylallyl 
diphosphate; GPP, geranyl diphosphate; FPP, farnesyl diphosphate; GGPP, geranylgeranyl 
diphosphate; SPP, slanesyl diphosphate; PPP, phytyl diphosphate. Enzymes are shown in bold: 
DXS, deoxyxylulose 5-phosphate synthase; GGPPS, GGPP synthase; PSY, phytoene synthase; PDS, 
phytoene desaturase; ZISO, ζ-carotene isomerase; ZDS, ζ-carotene desaturase; CRTISO, 
carotenoid isomerase; LCYE, lycopene ε-cyclase; LCYB, lycopene β-cyclase; CYP97C, carotene ε-
hydroxylase; CYP97A, cytochrome P450 carotene β-hydroxylase; BCH, non-heme di-iron carotene 
β-hydroxylase; ZEP, zeaxanthin epoxidase; VDE, violaxanthin de-epoxidase; NSY, neoxanthin 
synthase. 
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Figure 5. Carotenoid biosynthesis pathways in bacteria and archaea. C50 bacterioruberin, 
synthesized mainly by archaea, is highlighted in pink. Representative intermediates and products 
of the main pathways cited in the text are shown (highlighted in light blue). Glucoside esters of 
zeaxanthin, b-cryptoxanthin and OH-diaponeurosporene are also included. 
 
 
 
 
 
 
Figure 6. Carotenoid biosynthesis pathways in fungi. Major steps from -carotene to produce 
astaxanthin, neurosporaxanthin, torularhodin, and 3,3’-dihydroxy-,-carotene-4,4’dione (DCD) 
are shown. The most abundant carotenoids in fungi are boxed in orange. DCD and 3-hydroxy-
3’4’-didehydro-,-caroten-4-one. (HDCO) are side products of astaxanthin biosynthesis in X. 
dendrorhous. Plectaniaxanthin and phillipsiaxanthin are unusual carotenoids identified 
in Dioszegia sp. and Phillipsia carminea.   
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Figure 7. Carotenoid biosynthesis pathways in microalgae. Only biosynthetic steps from 
lycopene are shown.  
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Figure 8. Cleavage of carotenoid substrates by plant CCD enzymes. Scissors indicate the 
positions cleaved by members of the enzyme families shown in the box. 
  
74 
 
 
 
 
Figure 9. Retinoid biosynthesis pathways in animal cells. The enzyme -carotene 15,15′-
oxygenase 1 (BCO1) cleaves 15,15′ double bonds (shown in blue), whereas BCO2 cleaves 9′,10′ 
double bonds (shown in red). ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenase; 
LRAT, lecithin:retinol acyltransferase; RDH, retinol dehydrogenase; REH, retinyl ester hydrolase.  
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Figure 10. Overview of cellular carotenoid metabolism and interaction with retinoid 
metabolism in mammal cells. Carotenoids and retinyl esters (RE) contained in circulating 
lipoproteins are internalized in cells through the action of different lipoprotein receptors (SR-BI, 
LDLr), membrane transporters (CD36), and lipoprotein lipase (LPL). Within the cells, carotenoids 
associate to carotenoid-binding proteins (CBP) and incorporate into cytoplasmic lipid droplets 
and plasma and mitochondria membranes. Symmetric cleavage of provitamin A carotenoids such 
as β-carotene by BCO1 directly renders retinal. Carotenoids are also asymmetrically cleaved 
through the action of mitochondrial BCO2. Carotenoid cleavage products (CCPs) can be converted 
into retinal by BCO1. Retinal is also produced from retinol. Circulating retinol bound to retinol 
binding protein (RBP) is internalized in cells through the action of specific surface receptors 
(STRA6, RBPR2) or by diffusion across the plasma membrane. Inside the cell, retinol binds to the 
cellular retinol binding protein (CRBP) and can be stored as RE in lipid droplets upon esterification 
to fatty acids by lecithin:retinol acyltransferase (LRAT). RE hydrolase (REH) releases retinol from 
RE. Retinol and retinal can be interconverted by reversible oxidization catalyzed by short-chain 
dehydrogenase/reductases with retinol dehydrogenase (RDH) activity or medium-chain alcohol 
dehydrogenases (ADH). Retinal is further oxidized irreversibly to retinoic acid (RA) by the action 
of aldehyde dehydrogenases (ALDH). RA is transferred to the nucleus in association with specific 
intracellular lipid binding proteins (CRABP and FABP5) or can be catabolized by cytochrome P450 
enzymes (CYP) to more oxidized products that are eventually eliminated from the cell. Circulating 
albumin-bound RA (and likely other CCPs) can be taken up by cells. Intact carotenoids, retinoids, 
and other CCPs can modify gene expression through physical and/or functional interaction with 
nuclear receptors (NRs) and other transcription factors. They can play additional functions as light 
filters, antioxidants and prooxidants, and have other effects not directly related to the regulation 
of gene expression. 
